書籍詳細

I. わが国における小児期悪性固形腫瘍の概観

P.11 掲載の参考文献

• 1) 母子衛生の主なる統計:厚生省児童家庭局母子衛生課監修, p56-57, p62-67, 1995.

• 2) Miller RW, McKay FW:Decline in U. S. childhood cancer mortality, JAMA 251:1567-1570, 1984.
  pubmed

• 3) 小林 登, 松井一郎:わが国における小児癌全国登録, 図説臨床[癌]シリーズ no. 13, 小児の癌, メジカルビュー社, p14-19, 1987.

• 4) Young Jr. JL, Miller RW:Incidence of malignant tumors in U. S. children. J Pediatr 86:254-258, 1975.

• 5) がんの子供を守る会:平成2年度 (1990) 小児悪性新生物 全国登録委員会報告. 小児がん 28:733-755, 1992.

• 6) がんの子供を守る会:小児悪性新生物全国登録, 平成4年度 (1992). 小児がん 32:81-109, 1995.

• 7) Hirayama T:Descriptive and analytical epidemiology of childhood malignancy in Japan, Recent advances in managements of children with cancer, ed. by Kobayashi, N. The Children's Cancer Association of Japan, December 12-14, Tokyo, p27-43, 1979.

• 8) 別所文雄:小児固形腫瘍の疫学. 小児内科 18:321-329, 1986.

• 9) 塙 嘉之:Global にみた小児癌の疫学, 図説臨床「癌」シリーズ no. 13, 小児の癌, メディカルビュー社, p20-26, 1987.

• 10) 母子衛生の主なる統計:厚生省児童家庭局母子衛生課監修, p97-98, 1995.

• 11) Bessho F, Hashizume K, Nakajo T, et al:Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 119:237-241, 1991.

• 12) Sawada T, Matsumura T, Kawakatsu H, et al:Long term effect of mass screening for neuroblastoma in infancy. Am J Pediatr Hematol Oncol 13:3-7, 1991.

• 13) 角田昭夫:これからの神経芽細胞腫マス・スクリーニソグ. 小児外科 24:88-92, 1992.

• 14) 日本小児がん学会悪性腫瘍委員会報告:小児がん 28:23-28, 1990.

• 15) 土田嘉昭:小児期固形腫瘍-最近の治療の進歩. 小児科 34:329-338, 1993.

• 16) D'Angio GJ:Oncology seen through the prism of Wilms tumor. Medical and Oncology 13:53-58, 1985.

• 17) Jadresic L, Leake J, Gordon I, et al:Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr 117; 717, 1990.
  pubmed

• 18) 植田高広, 宗像恵美子, 山本正生:FGSの腎病変を認めたウイルムス腫瘍の1幼児例. 第9回日本小児がん学会報告, 1993.

II. 診断総論

P.23 掲載の参考文献

• 1) Sawada T, Todo S, Fujita K, et al:Mass screening of neuroblastoma in infancy. Am J Dis Child 136:710-712, 1982.
  pubmed

• 2) Hanai J, Kawai T, Sato Y, et al:Simple liquid-chromatographic measurement of urinary vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants. Clin Chem 33:2043-2046, 1987.
  pubmed

• 3) Nishi M, Miyake H, Takeda T, et al:Effects of mass screening of neuroblastoma in Sapporo City. J Pediat Surg 25:545, 1990.

• 4) Hanawa Y, Sawada T, Tsunoda A:Decrease in childhood neuroblastoma death in Japan. Med Ped Oncol 18:472-475, 1990.

• 5) 武田武夫, 西 基:マススクリーニングで神経芽腫が疑われた例の扱い方. 小児科診療 50:1532-1537, 1987.

• 6) Takeda T, Shimada M, Nakadate H, et al:Current status of mass-screening for neuroblastoma in Sapporo City. Edt by Wilcken B and Webster D:Neonatal screening in the nineties. The Kelvin Press, Manly Vale, pp146-147, 1991.

• 7) 武田武夫, 島田昌子, 花井潤師:神経芽細胞腫の腫瘍マーカー. CRC 1:16-23, 1992.

• 8) 武田武夫, 島田昌子, 西 基ほか:先天性奇形と小児悪性腫瘍. 癌の臨床 38:629-635, 1992.

• 9) Φster J, Mikkelsen M, Nielsen A:Mortality and life-table in Down's syndrome. Acta Paediatrica Scand 64:322-326, 1975.

• 10) 畑江芳郎, 武田武夫, 中舘尚也ほか:Transient abnormal myelopoiesis (TAM) 経過後の急性白血病. 臨床血液 31:1939-1944, 1990.

• 11) Miller BW, Fraumeni JFJr, Manning MD:Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922-927, 1964.

• 12) Breslow NE, Beckwith JB:Epidemiological features of Wilms' tumor:results of the National Wilms' Tumor Study. J Natl Cancer Inst 68:425-436, 1982.

• 13) Huson SM, Compston DAS, Harper PS:A genetic study of von Recklinghausen neurofibromatosis (NF1) in South East Wales 1:Prevalence, fitness, mutation rate and effect of parental transmission on severity. J Med Genet 26:704-710, 1989.

• 14) Schumacher R, Mai A, Gujahr P:Association of rib anomalies and malignancy in childhood. Eur J Pediatr 151:432-434, 1992.
  pubmed

P.36 掲載の参考文献

• 1) Majd M:Radionuclide imaging in pediatrics. Pediatr Clin North Am 32:1559, 1985.

• 2) Wells SK:The value of skull radiography in children with intracranial tumors, Clin Radiol 36:253, 1985.
  pubmed

• 3) Valk J:Gd-DTPA in MR of spinal lesion. AJNR 9:345, 1988.

• 4) Marglin SI, Custellino RA:Selction of imaging studies for newly-presenting patients with non-Hodgkin's lymphoma. Semin Ultra Sound CT MR 7:2, 1986.

• 5) Gainey MA, Capitanio MA:Recent advances in nuclear medicin. Radiol Clin North Am 26:409, 1988.
  pubmed

• 6) Garty I, Friedman A, Sandler MP, et al:Neuroblastoma. Imaging evaluation by sequental Tc-99mMDP, I-1311MIBG and Ga-67 citrate studies. Clin Nucl Med 14:515, 1989.

• 7) Jacobs A, Delree M, Desprechins B, et al:Consolidation the role of I-MIBG scintigraphy in childhood neuroblastoma five years of clinical experience. Pediatr Radiol 20:157, 1990.
  pubmed

• 8) Hayden CK, Swischuk LE:Pediatric ultrasonography. William & Wilkins, Baltimore, 1987.

• 9) D'Anginocourt L:Spiral scan capability increases utility of CT. Diagnostic Imaging 98, march, 1991.

• 10) Brasch RC:Ultrafast computed tomography infants and children. Radiol Clin North Am 26:277, 1988.
  pubmed

• 11) Bisset GS:Magnetic resonance imaging in pediatric patient. Pediatric Annals 21:121, 1992.
  pubmed

• 12) Fletcher BD, Pratt CB:Evaluation of the child with a suspected malignant solid tumor. Pediatr Clin North Am 38:223, 1991.
  pubmed

• 13) Hennig J, Naureth A, Friedburg H:RARE-imaging. A fast imaging method for clinical MR. Magn Reson Med 3:823, 1986.
  pubmed

• 14) Haase A, Matthaei W, Bartkowski R, et al:Inversion recovery snap short flash MR imaging. J Comput Assist Tomogr 13:1036, 1989.

• 15) Parker BR, Moore SG:Imaging studies in the diagnosis of pediatric malignancies. ed Pizzo PA, Poplack DG:Principles and Practice of Pediatric Oncology. P163 JB Lippincott, Philadelphia, 1993.

• 16) Baierl P, Muhlsteffen A, Haustein J, et al:Comparison of plain and Gd-DTPA-enhanced MR-imaging. Pediatr Radiol. 20:515, 1990.
  pubmed

• 17) 成瀬昭二, 古谷誠一, 田中忠蔵:MRSとMRSI. 臨床画像 9(2):84, 1993.

• 18) 竹中栄一, 須田善雄, 土屋一洋:MRIおよびNMR in vivo スペクトロスコピーの現状と問題点. 臨床画像 3(6):10, 1987.

• 19) Kirk IR, Dominguez R, Castillo M:Congenltal primary cerebral angiosarcoma, CT US and MR finding. Pediatr Radiol 22:134, 1992.

• 20) Menor F, Martil-Bonmati L, Mulas F, et al:Imaging considerations of central nervous system mainifestations in pediatric patients with neurofibromatosis type 1. Pediatr Radiol 21:389, 1991.

• 21) Teasdale GM, Hadley DM, Lawrence A:Comparison of magnetic resonance imaging and computed tomography in suspected lesions in the posterior cranial fossa. Br Med J 299:349, 1989.

• 22) 土屋洋一, 竹中栄一:脳疾患における有用性. 臨床画像 3(6):17, 1987.

• 23) Siegel MJ, Nadel SN, Glazer HS, et al:Mediastinal lesions in children comparison of CT and MR. Radioloy 160:241, 1985.

• 24) Levitt RG, Glazer HS, Roper CL, et al:Magnetic resonance imaging of mediastinal and hilar masses comparison with CT. AJR 145:9, 1989.

• 25) Molina PL, Siegel MJ, Glazer HS:Thymic masses on MR imaging. AJR 155:495, 1990.
  pubmed

• 26) Bergin CJ, Carlsen SE, Healy MV, et al:MR imaging evaluation of chest wall lymphoma. Radiology 177:97, 1990.

• 27) Merten DF, Kirks DR:Diagnostic imaging pf pediatric abdominal masses. Pediatr Clin North Am 32:1397, 1985.

• 28) 上者郁夫, 清水光春, 山本淑雄ほか:腹部疾患における有用性. 臨床画像 3(6):50, 1987.

• 29) Finn JP, Hall-Craggs MA, Dick-Mireaux C, et al:Primary malignant liver tumors in childhood assesment of resectability with high-field MR and comparison with CT. Pediatr Radiol 21:34, 1990.

• 30) 藤岡睦久:小児の画像診断. p164, 医学書院, 1986.

• 31) Eftekhari F, Erly WK, Jaffe N:Malignant rhabdoid tumor of the kidney imaging features in two cases. Pediatr Radiol 21:39, 1990.
  pubmed

• 32) Moore SG, Berry G, Smith JT, et al:Extent of marrow and soft tissue involvment in pediatric bone tumors. Magnetic resonance and pathologic correlation. AJR 153:202, 1989.

• 33) Bronskill MJ, Henkelman RM, Poon PY, et al:Magnetic resonance imaging, computed tomography and radionuclide scintigraphy in detection of liver metastases. J Can Assoc Radiol 39:3, 1988.

P.47 掲載の参考文献

• 1) 澤口重徳:小児腹部腫瘤の診断手順, 悪性腫瘍を中心として. 外科診療 19:383-392, 1977.

• 2) 永山徳郎ほか:小児科領域における超音波診断法. 日臨 21:2260-2268, 1963.
  Medical*Online

• 3) 川勝秀一ほか:神経芽細胞腫マススクリーニング陽性例の初診時画像診断. 日小学会誌 97:1199-1202, 1993.

• 4) 村国 均ほか:小児後腹膜奇形腫の1例, 本邦小児文献報告219例の統計的考察. 日小外会誌 21:111-116, 1985.

• 5) 富本喜文ほか:腹部外傷を契機に発見された後腹膜paragangliomaの2例. 小児がん 30:127-132, 1993.

• 6) 中村博史ほか:下大静脈内腫瘍塞栓を伴ったWilms腫瘍の1例. 日小外会誌 28:926-931, 1992.

• 7) 山口宗之:超音波エコー. 図説臨床[癌]シリーズ (山村雄一, 杉村隆監修), No.13 小児の癌. pp42-46, メジカルビュー社, 東京, 1987.

• 8) 辻本文雄:副腎. 腹部超音波テキスト-上・下腹部- (改訂版), 辻本文雄編, pp140-143, ベクトル・コア, 東京, 1992.

• 9) 幕内雅敏ほか:肝胆膵の超音波解剖. 臨床医10:266-272, 1984.

• 10) 山口宗之ほか:腹腔内破裂をきたした肝芽腫の1例. 日小外会誌 25:709-713, 1989.

P.53 掲載の参考文献

• 1) LaBrosse EH, et al:Urinary excretion of 3-methoxy-4-hydfoxymandelic acid and 3-methoxy-4-hygroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 40:1995-2001, 1980.
  pubmed

• 2) 小泉昌一:VMA, HVA, 小児の臨床検査指針90. 小児科診療 53(Suppl.):706-708, 1990.

• 3) 沢田 淳ほか:神経芽細胞腫の6カ月乳児を対象としたマススクリーニングの問題点. 小児科診療 54:2609-2616, 1991.

• 4) 高杉信男ほか:神経芽腫のマススクリーニング. 小児科診療 50:1520-1525, 1987.

• 5) Brodeur GM, et al:Internationl criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 16:1874-1881, 1988.

• 6) 石黒士雄ほか:神経芽細胞腫の新しい血中マーカー物質. 日小外会誌 18:1303-1309, 1982.

• 7) Tsuchida Y, et al:Serial detemination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors. J Pediatr Surg 22:419-424, 1987.

• 8) 土田嘉昭ほか:小児固型悪性腫瘍の進歩-腫瘍マーカーを中心に-. 小児科診療 52:215-223, 1989.

• 9) Zeltzer PM, et al:Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 2:361-363, 1983.
  pubmed

• 10) Tsuchida Y, et al:Evaluation of alpha-fetoprotein in early infancy. J Pediatr Surg 13:155-156, 1978.
  pubmed

• 11) Tsuchida Y, et al:Difference in the structure of alpha-fetoprotein and its clinical use in pediatric surgery. J Pediatr Surg 20:260-265, 1985.
  pubmed

• 12) Tsuchida Y, et al:The ratio of fucosylation of alpha-fetoprotein in hepatoblastoma. Cancer 63:2174-2176, 1989.
  pubmed

• 13) 金子道夫ほか:PHA-E4 レクチンによる血清α-フェトプロテインの分画分析. 日小外会誌 25:1040-1047, 1989.

• 14) Carachi R, et al:Inactive renin:A tumor marker in neuroblastoma. J Pediatr Surg 22:278-280, 1987.

• 15) 餅田良顕ほか:モノクローナル抗体による血漿総レニン濃度の測定, ウイルムス腫瘍の腫瘍マーカーとしての有用性の検討. 医学のあゆみ148:129-130, 1989.

• 16) Cooper EH, et al:Serum hyluronic acid levels in cancer. Br J Cancer 58:668-669, 1988.

• 17) Longaker MT, et al:Hyaluronic acid-stimulating activity in the pathology of Wilms' tumor 82:135-139, 1990.

• 18) 伊藤節子:性腺ホルモンhCG, hCG-β. 検査と技術 16:849-852, 1988.

• 19) 伊勢 泰ほか:小児腫瘍と癌胎児性抗原 (carcinoembryonic antigen). 小児科 18:597-601, 1977.

• 20) O'Connor DT, et al:Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Eng J Med 314:1145-1151, 1986.

• 21) Hisao J, et al:Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. J Clin Invest 85:1555-1559, 1990.

• 22) 絹巻 宏:各種腫瘍マーカーによる診断技術の進歩, Lactic dehydrogenase. 小児外科 18:49-56, 1986.

• 23) Kinumaki H, et al:Serum lactate dehydrogenase isoenzyme-1 in children with yolk sac tumor. Cancer 56:178-181, 1985.
  pubmed

• 24) Sacks SS, et al:Increase in lactate dehydrogenase isozyme-1 in plasma in pediatric malignancy. Clin Chem 36:1683-1685, 1990.
  pubmed

• 25) 広津卓夫:Isoferritin. 小児の臨床検査指針90. 小児科診療 53(Suppl):710-712, 1990.

• 26) 恒松由記子ほか:各種腫瘍マーカーによる診断技術の進歩, Ferritin. 自験例の検討. 小児外科 18:89-96, 1986.

• 27) 松田好史ほか:癌患老血清中に存在する免疫抑制酸性蛋白 (IAP) の性状と免疫抑制活性. 医学のあゆみ 105:154-157, 1978.

• 28) 中條俊夫ほか:IAP (Immunosuppressive acidic protein) と小児癌. 小児外科 18:41-48, 1986.

P.61 掲載の参考文献

• 1) Hayashi Y, et al:Chromosome findings and prognosis in neuroblastoma with emphasis on marker chromosome l. Cancer 63:126-132, 1989.

• 2) Hayashi Y, et al:Biology of neuroblastomas in Japan found by screening. Amer J Pediat Hematol Oncol 14:342-347, 1992.

• 3) Brodeur M, et al:Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984.

• 4) Seeger, et al:Association of multiple copies of the N-myc oncogene with rapid progression on neuroblastomas. N Engl J Med 313:1111-1116, 1985.

• 5) Hayashi Y, et al:Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene. Int J Cancer 45:705-711, 1990.

• 6) Fong CT, et al:Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastoma:Correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753-3757, 1989.

• 7) Suzuki T, et al:Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 49:1095-1098, 1989.
  pubmed

• 8) Tanaka T, et al:Expression of Ha-ras oncogene products in human neuroblastomas and significant correlation with a patient's prognosis. Cancer Res 48:1030-1034, 1988.

• 9) Nakagawara A, et al:Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854, 1993.
  pubmed

• 10) Suzuki T, et al:Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377-384, 1993.
  pubmed

• 11) Delattre O, et al:Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165, 1992.
  pubmed

• 12) 林 泰秀ほか:Tyrosine hydroxyrase mRNAとt(11;22)-キメラmRNAを用いた神経芽腫とユーイング肉腫の遺伝子診断. 小児がん30:337-340, 1993.

• 13) Komuro H, et al:Mutations of p53 gene were involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53:5284-5288, 1993.

• 14) Shapiro DN, et al:Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adorescents with unresectable rhabdomyosarcoma. J Clin Oncol 9:159-166, 1991.
  pubmed

• 15) Hosoi H, et al:Differential expression of myogenic regulatory genes, MyoD1 and myogenin, in human rhabdomyosarcoma sublines. Int J Cancer 50:977-983, 1992.
  pubmed

• 16) Barr FG, et al:Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 3:113-117, 1993.
  pubmed

• 17) Scrable H, et al:Amodel for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86:7480-7484, 1989.

• 18) Crozat A, et al:Fusion of CHOP to a novel RNA binding protein in human myxoid liposarcoma. Nature 363:640-644, 1993.
  pubmed

• 19) Call KM, et al:Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 wilms' tumor locus. Cell 60:509-520, 1990.
  pubmed

• 20) Tadokoro K, et al:Intragenic homozygous deletion of the WT1 gene in Wilms' tumor. Oncogene 7:1215-1221, 1992.
  pubmed

• 21) Pelletier J, et al:Germ line mutations in the Wilm's tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991.

• 22) Bruening W, et al:Germline intronic and exonic mutations in the Wilm's tumor gene (WT1) affecting urogenital development. Nature Genet 1:144-148, 1992.

• 23) Knudson AG:Mutation and Cancer; Statistical study of relinoblastoma. Proc Natl Acad Sci USA 68:820-823, 1971.
  pubmed

• 24) Lee WH, et al:Human retinoblastoma susceptibility gene:Cloning, identification, and sequence. Science 235:1394-1399, 1987.
  pubmed

• 25) Toguchida J, et al:Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338:156-158, 1989.
  pubmed

• 26) Li Y, et al:Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275-281, 1992.
  pubmed

• 27) Trofatter JA, et al:A novel Moesin-, Ezrin-, Radixin-like gene is a candidate for neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993.
  pubmed

• 28) Wilkins RJ, et al:Genomic imprinting and carcinogenesis. Lancet I:329-331, 1988.
  pubmed

• 29) Reik W, Surani MA:Genomic imprinting and embryonal tumours. Nature 338:112-113, 1989.
  pubmed

III. 治療総論

P.71 掲載の参考文献

• 1) 星野一正:医学とバイオエシックス. 檜學, 島久洋・編. 医学概論, 朝倉書店, 東京, p11-18, 1990.

• 2) アメリカ病院協会. 患者の権利章典, 1973.

• 3) 厚生省. 国民医療対策本部中間報告, 1988.

• 4) 日本医師会諮門生命倫理懇談会答申, 1990.

• 5) National Commission for the Protection of Human Subjects of Biomedical and Bihavioral Research. The Belmont Report, GPO 887-809. US Government Printing Office, Washington, 1983.

• 6) American College of Physicians Ethics Manual Ann Intern Med 101:129, 1984.
  pubmed

• 7) ベーカーS(細谷亮太・訳):君と白血病 (新訂版). 医学書院, 東京, 1989.

• 8) タッカーJB(朝長梨枝子・訳):エリー; 少女と白血病の闘いの記録. 保健同人社, 東京, 1985.

• 9) 西村昴三, 細谷亮太:御両親のためのハソドブックfor LEUKEMIA. 厚生省「小児白血病の治療に関する研究班」, 1987.

• 10) 細谷亮太:悪性腫瘍の患児とその家族へのかかわり方; 病名告知と病気の受容を中心に. 小児看護 12(8):1027-1030, 1987.

• 11) O'Connor PA:Truth felling in pediatrics; by degrees. Prog Clin Biol Res 139:189-194, 1983.

• 12) 45 Code of Federal Regulations 46. Subpart D; Additional protections for children involved as subjects in research. Federal Register 48:9818, 1983.

• 13) Ingelfinger FJ:The unethical in medical ethics. Ann Intern Med 83:264-269, 1975.
  pubmed

• 14) 木内道祥:「エホバの証人」と輸血拒否; その対応策. 救急医学 10:187-195, 1986.

• 15) 細谷亮太:死期の近い子. 小児内科 25(増):634-637, 1993.

• 16) 細谷亮太:小児がん患児の在宅ケア (I)(II) 平成3年及び4年度厚生省心身障害研究「市町村母子保健活動の効率化に関する研究班」分担研究, 小児慢性特定疾患児の在宅ケアに関する研究報告書, p32-39, p61-67, 1991.

P.79 掲載の参考文献

• 1) 重松 康:放射線治療の適応症と一般的な施行法, 田坂 晧編; 放射線医学大系, 第30巻, p136, 中山書店, 1983.

• 2) Thomlinson RH, Gray LH:The histological structure of some human lung cancers and the possible implications for radiotherapy. Brit J Cancer 9:539-549, 1955.
  pubmed

• 3) 堀内淳一:特集, 口腔癌, 治療方針とその選択-放射線治療の立場から-. JOHNS 6:207-212, 1990.

• 4) 亘理 勉:固形腫瘍難治例の放射線療法の役割, 藤本孟男編; 小児癌-最新の治療トピックスと包括管理-pp169-182, 癌と化学療法社, 1984.

• 5) Sy Ortin TT, Shostak CA, Donaldson S:Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood:The Stanford experience. Int J Radiation Oncol Biol Phys 19:873-880, 1990.

• 6) 正木英一:小児腫瘍, 橋本省三編; 放射線腫瘍学, pp217-240, 1986.

• 7) 亘理 勉:小児腫瘍, 柄川順編; 新版 癌・放射線療法, pp340-350, 篠原出版, 1987.

• 8) 堀内淳一, 渋谷 均, 松本 悟, 神山隆一:頭頸部リンパ節外初発の非ホジキンリンパ腫. 癌の臨床 34:631-635, 1988.

P.85 掲載の参考文献

• 1) 東 英一, 櫻井 實:小児癌の免疫療法の最近の治療成績. 小児科 24:957-968, 1983.

• 2) Azuma E, Sakurai M, et al:Leukemia-specific serum form a child showing an immunofluorescent pattern distinct from J-5 monoclonal antibody directed for CD10 (common ALL antigen). Biomed Pharmacother 44:269-276, 1990.

• 3) 東 英一, 櫻井 實:免疫調節剤とその適応疾患. 小児科 25:119-128, 1984.

• 4) Azuma E, Yamamoto H, Kaplan J:Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. J Immunol 143:1524-1529, 1989.
  pubmed

• 5) Azuma E, Sakurai M, et al:Autologous tumor-specific cytotoxic T-lymphocytes in a child with neuroblastoma. Biomed Pharmacother 44:487-493, 1990.

• 6) Azuma E, Sakurai M, et al:Cytotoxic T-lymphocytes in neuroblastoma. Int J Immuno ther 7:73-79, 1991.

P.95 掲載の参考文献

• 1) Schimpff SC:Empiric antibiotic therapy for granulocytopenic cancer patients. Bull NY Acad Med 58:750-756, 1982.

• 2) Pizzo PA:Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J Pediatr 98:341-354, 1981.

• 3) Pizzo PA:Infectious complications in the child with cancer. II. Management of specific infectious organisms. J Pediatr 98:513-523, 1981.
  pubmed

• 4) Albano E, Pizzo PA:Infectious complications in childhood acute leuukemias:Pediatr Clinic North Amer 35:873-901, 1988.

• 5) Gootenberg JE, Pizzo PA:Optimal management of acute toxicities of therapy. Pediatr Clin North America 38:269-297, 1991.

• 6) Hirotsu T, Akatsuka J:Infectious complications in childhood leukemia. Acta Pediatr Jpn 33:564-572, 1991.

• 7) Barson WJ, Brady MT:Management of infections in children with cancer. Hematol/Oncol Clin North America 1:801-839, 1987.

• 8) Hughes WT, Armstrong D, Bodey GP, et al:Guidelines for the use of anti-microbial agents in neutropenic patients with unexplained fever. J Infect Dis 161:381-396, 1990.
  pubmed

• 9) 赤塚順一, 広津卓夫, 星 順隆ほか:小児血液・腫瘍疾患患児の深在性真菌症に対するfluconazolの有用性に関する検討. 化学療法の領域 11:139-150, 1995.

• 10) 宮崎澄雄:補助療法. 小児医学 21:116-128, 1988.

• 11) 月本一郎, 沢 文博, 小原 明ほか:小児血液腫瘍疾患の好中球減少時に合併した重症感染症に対するceftazidime(CAZ)の臨床効果. 小児科診療 51:1105-1108, 1988.

• 12) Brown AE:Management in the febrile, neutropenic patient with cancer:therapeutic considerations. J Pediatr 106:1035-1042, 1985.
  pubmed

• 13) Hathom J, Rubin M, Pizzo PA:Empiric antibiotic therapy in the febrile neutropenic cancer patients:Clinical efficacy and impact of monotherapy. Antimicrob Agents Chemother 31:971-977, 1987.

• 14) Cornelissen JJ, de Graeff A, Verdonck LF, et al:Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients. Antimicrob Agents Chemother 36:801-807, 1992.
  pubmed

• 15) Rolston KV, Berkey P, Bodey GP, et al:A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med 152:263-291, 1992.
  pubmed

• 16) Feliu J, Artal A, Gonzalez Baron M, et al:Comparison of two antibiotic regimens (Piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer. Antimicrob Agents Chemother 36:2816-2820, 1992.
  pubmed

• 17) Malik IA, Abbas Z, Karim M:Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 339:1092-1096, 1992.
  pubmed

P.102 掲載の参考文献

• 1) Asano S:Human granulocyte colony-stimulating factor:Its basic aspects and clinical applications. Amer J Pediatr Hematol Oncol 13:400-413, 1991.

• 2) 別所正美:サイトカインの臨床応用. 中外医学社, 東京, 1992.

• 3) 元吉和夫:M-CSFの臨床応用. 癌治療と宿主 3:145-150, 1991.

• 4) Nomura H, Imaazeki I, Oheda M, et al:Purification and characterization of human granulocyte colony-stimulation factor (G-CSF). EMBO J 5:871-876, 1986.

• 5) Nagata S, Tsuchiya M, Asano S, et al:Molecular cloning and expression of cDNA for human granulocyte colony-stimulation factor. Nature 319:415-417, 1986.

• 6) 上田一博, 塙 嘉之, 高久史麿ほか:小児好中球減少症に対するRecombinant human G-CSF(rG-CSF注) の臨床検討. 臨床血液 23:212-219, 1991.

• 7) 今宿晋作, 土田昌宏, 佐々木道子ほか:小児先天性好中球減少症に対するKRN8601(rhG-CSF) の投与効果. 日小血会誌 4:420-427, 1990.

• 8) 月本一郎ほか:小児悪性腫瘍に対する recombinant Human G-CSF(rG-CSF注)の臨床検討. 臨床血液 31:1647, 1990.

• 9) Okamura J, Yokoyama M, Tsukimoto I, et al:Treatment of chemotherapy induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor. Pediat Hematol Oncol 9:199, 1992.

• 10) Budel LM, et al:Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 74:2668, 1990.

• 11) 又野禎也ほか:急性白血病におけるrhG-CSFの使用経験. 臨床血液 31:1234, 1990.

• 12) Ohno R, et al:Effect of granulocyte colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia:A randomizd control study. New Eng J Med 323:871, 1990.
  pubmed

• 13) Tsuchiya H, et al:Responses to granulocyte colony-stimulating factor (G-CSF) and granulocytemacrophage CSF in Ph1 positive acute lymphoblasiticleukemia with myeloid surface markers. Blood 77:411, 1991.

• 14) Tsukimoto I, et al:Effect of G-CSF after intensive consolidation therapy on relapsed acute lymphoblastic leukemia in children. (Buechner et al, eds), Acute Leukemia IV. Prognostic factors. p215, Springer-Verlag, Berlin 1993.

• 15) Masaoka T, et al:Recombinant human granulocyte-colony stimulating factor in allogeneic bone marrow transplantation. Exp Haematol 17:1047-1050, 1989.

P.112 掲載の参考文献

• 1) 田村 眞:血液・血液製剤の種類と特徴, 和田 攻, 他, 編, 輸血血液製剤ガイドp38-45, 文光堂, 東京, 1995.

• 2) 日本赤十字本社:血液製剤一覧 (1994).

• 3) American Association of Blood Bank:Technical mannual, 10th ed., 1990.

• 4) 原田博道:白血球除去赤血球(LPRC)製剤製造に関するプロセス・バリデーショソ. 第43回日本輸血学会総会ラソチョンセミナーにて発表, 1995.

• 5) Doll D, Weiss RB:Neoplasia and the erythron. J Clin Oncol 3:429-446, 1985.
  pubmed

• 6) Rao SP, Miller ML, Cohen BJ:Severe anemia due to B19 parvovirus infection in children with acute lymphocytic leukemia. Am J Pediatr Hematol Oncol 12:194-197, 1991.

• 7) Gottlieb RA, Pinkel D (藤本孟男監訳):小児癌の患者管理ハンドブック. メディカル・サイエンス・インターナショナル, 143, 1992.

• 8) Buchanan GR:Hematologic supportive care of the pediatric cancer patient. Pizzo PA and Poplack DG, ed, Principles and practice of pediatric oncology, 2nd ed, JB Lipincott, Philadelphia, 1993.

• 9) Strauss RA, Gloster ES, McGallister JA, et al:Acute cytoreductibn techniques in the early treatment of hyperleuocytosis associated with childhood hematologic malignancies. Med Pediatr Oncol 13:346-411, 1985.

• 10) Neiburg PI, Stockman JA III:Rapid correction of anemia with partial exchange transfusion. Am J Dis Child 131:60-61, 1977.

• 11) Gaydos AL, Freireich EJ, Mantel N:The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 266:905-909, 1962.

• 12) 月本一郎:小児輸血療法の現況と今後の展望. 日小血会誌 7:177-186, 1993.

• 13) 渋谷温:新生児輸血の方法と問題点. Med Practice(臨時増刊号):188-191, 1992.

• 14) Gmur J, Burger J, Schanz U, et al:Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338:1223-1226, 1991.
  pubmed

• 15) 高本 滋:骨髄移植と輸血. Modern Physician 14:323-325, 1994.

• 16) 半田 誠ほか:白血球除去フィルターを用いた血小板輸血の有効性に関する臨床的検討. 日輸血会誌 36:752-756, 1990.
  Medical*Online

• 17) 高橋孝喜, 十字猛夫:輸血によるGVHD. 臨床病理 88(増):148-155, 1991.

• 18) 片山透:輸血後のウイルス肝炎. 臨床病理 88(増):156-170, 1991.

• 19) 月本一郎ほか:C型肝炎. 小児科診療 54:838-844, 1991.

P.128 掲載の参考文献

• 1) 吉川 敏:自己骨髄移植. 日本臨牀臨 39:2850-2855, 1981.

• 2) Heizmann W, et al:Surveillance cultures and benefit of laminar airflow unit in patients undergoing bone marrow transplantation. Infection 15:337-343, 1987.
  pubmed

• 3) 気賀沢寿人ほか:小児における無菌ベットによる骨髄移植の成績. 日小血会誌 6:23-28, 1992.

• 4) 佐藤純子ほか:自家末梢血幹細胞移植術施行患者における造血機能回復の検討. 臨床血液 33:637-645, 1992.

• 5) Adorno G, et al:Bone marrow processing with a gravity sedimentation technique:experience of 13 cases. Haematologica 75 suppl 1:48-50, 1990.

• 6) Pritchard J, et al:High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86-94, 1982.
  pubmed

• 7) Angelo M, et al:High-dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy. Cancer 54:2836-2839, 1984.
  pubmed

• 8) Carey PJ, et al:Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 77:1593-1598, 1991.
  pubmed

• 9) Lazarus HM, et al:High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 10:1682-1689, 1992.
  pubmed

• 10) 比嘉敏夫ほか:自家骨髄移植時のpurgingと造血幹細胞の検討. 低温医学 18:12-17, 1992.
  Medical*Online

• 11) Zingsem J, et al:Bone marrow purging prior to autologous transplantation. Infusionstherapic 19:288-290, 1992.

• 12) Takaue Y, et al:Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer. Blood 74:1245-1251, 1989.
  pubmed

• 13) 福田 稔ほか:小児悪性腫瘍における化学療法後の末梢血液幹細胞について. 臨床血液 30:303-308, 1989.

• 14) Korbling M, et al:Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML:influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplantation 7:343-349, 1991.
  pubmed

• 15) Socinski MA, et al:Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet I:1194-1198, 1988.
  pubmed

• 16) Fukuda M, et al:Recombinant human granulocyte colony-stimulating factor enhances the release of peripheral blood stem cells following chemotherapy in childhood malignancies. Acta Haematol Jpn 53:916-922, 1990.

• 17) Fukuda M, et al:Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hogdkin's lymphoma. Br J Haematol 80:327-331, 1992.

• 18) To LB, et al:The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplantation 4:41-47, 1989.
  pubmed

• 19) 浅井 治ほか:成人悪性腫瘍における自家末梢血幹細胞移植に関する基礎的研究-とくに効率的な採取と保存法について-. 慈恵医大誌 107:485-496, 1992.

• 20) Kessinger A, et al:Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723-727, 1988.
  pubmed

• 21) 岡本康裕ほか:小児癌患者における自家末梢血幹細胞輸注に伴う副作用の検討. 臨床血液 33:317-321, 1992.

• 22) Haas R, et al:Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp Hematol 21:109-113, 1993.
  pubmed

• 23) Rabinowe SN, et al:Long-term follow-up of a phase III study recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies. Blood 81:1903-1908, 1993.
  pubmed

• 24) 正岡 徹ほか:骨髄移植におけるKRN8601 (rhG-CSF) の第II相臨床試験成績. 今日の移植 3:85-93, 1990.
  Medical*Online

• 25) Pene R, et al:Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation. Bone Marrow Transplantation 11:219-222, 1993.
  pubmed

• 26) 松山孝治ほか:名古屋第一赤十字病院における小児骨髄移植の実際. 今日の移植 5:235-245, 1992.
  Medical*Online

• 27) O'Dwyer PJ, et al:Phase I trail of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor. J Clin Oncol 1O:1352-1358, 1992.

• 28) Charak BS, et al:A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application. Bone Marrow Transplantation 11:147-154, 1993.
  pubmed

• 29) Ribeiro RC, et al:Continuous infusion of interleukin-2 in children with refractory malignancies. Cancer 72:623-628, 1993.
  pubmed

• 30) Fefer A, et al:interleukin-2 ± lymphocyte as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies. Acta Haematol 89 suppl 1:2-7, 1993.

• 31) Klingemann HG, et al:Treatmant with recombinant interferon (a-2B) early after bone marrow transplantation in patients at high risk for relapse. Blood 78:3306-3311, 1991.

• 32) Slavin S, et al:Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT). Leukemia 6 suppl 4:164-166, 1992.

• 33) 堀部敬三ほか:D. ハンディキャプ児の感染 5. 骨髄移植. 小児科 28 臨時増刊号:1345-1348, 1987.

• 34) Besnard M, et al:Systemic candida infection in pediatric BM autotransplantation:clinical signs, outcome and prognosis. Bone Marrow Transplantation 11:465-470, 1993.
  pubmed

• 35) Rowley SD, et al:Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation incidence and clinical significance. Tranfusion 28:109-112, 1988.

• 36) Dulley FL, et al:Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 43:870-873, 1987.
  pubmed

• 37) Brugieres L, et al:Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors; incidence, clinical course and outcome. Bone Marrow Transplantation 3:53-58, 1988.
  pubmed

• 38) Bianco JA, et al:Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78:1205-1211, 1991.
  pubmed

• 39) Attal M, et al:Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous of infusion low-dose heparin:a prospective, randomized trail. Blood 79:2834-2840, 1992.

• 40) Essell JH, et al:Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow translant patients. Bone Marrow Transplantation 10:367-372, 1992.

• 41) Glukman E, et al:use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 74:277-281, 1990.

• 42) Rio B, et al:N-terminal peptide of type III procollagen:a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplantation 11:471-472, 1993.

• 43) 宮島雄二ほか:骨髄移植後50日前後にみられる肝機能異常を伴った一過性の発熱-サイトメガロウイルス感染症の関与について-. 臨床血液 31:1670-1673, 1990.

• 44) Alvegard TA, et al:Pulmonary bone-marrow embolisation after unfiltrated autologous bone-marrow transplantation. Acta Pathol Microbiol Immunol Scand 92:81-82, 1984.

• 45) Ghalie R, et al:Evaluation of pulmonary complications after bone marrow transplantation:the role of pretransplant pulmonary function tests. Bone Marrow Transplantation 10:359-365, 1992.
  pubmed

• 46) Valteau D, et al:Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high dose chemotherapy without total-body irradiation. Transplantation 45:737-740, 1988.
  pubmed

• 47) Wingard JR, et al:Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432-1437, 1988.
  pubmed

• 48) Winston DJ, et al:Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplantaion 8:7-11, 1991.

• 49) Millard FC, et al:The chest radiograph appearances seen following high dose chemotherapy and autologous bone marrow transplantation for resistant malignant lymphoma. Br J Radiol 64:103-106, 1991.
  pubmed

• 50) Carlson K, et al:Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) ± TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplantation 11:205-208, 1993.

• 51) Tarbell NJ, et al:Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radioth Oncol (suppl 1):139-142, 1990.

• 52) Van der Jagt RHC, et al:Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplantation 8:211-215, 1991.

• 53) Callum JL, et al:Influence of total body irradiation on infections after autologous bone marrow transplantation. Bone Marrow Transplantation 8:245-251, 1991.
  pubmed

• 54) Dopfer R, et al:Influence of allogeneic bone marrow transplantation on the endocrine system in children. Folia Haematol 116:541-545, 1989.
  pubmed

• 55) Schmidt GM, et al:Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 55:551-557, 1993.
  pubmed

• 56) Mascarin M, et al:Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer 68:655-659, 1991.
  pubmed

• 57) Greenbaum-Lefkoe B, et al:Syndrome of inappropriate antidiuretic hormone secretion. A complication of high-dose intravenous melphalan. Cancer 55:44-46, 1985.
  pubmed

• 58) Salvadore de Oliveira J, et al:Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan. Bone Marrow Transplantation 11:163-167, 1993.

• 59) Gordon BG, et al:Thrombotic complications of BMT:association with protein C deficiency. Bone Marrow Transplantation 11:61-65, 1993.
  pubmed

• 60) Shinohara O, et al:Growth and growth hormon secretion in children after bone marrow transplantation. Acta Paediatrica Japonica 35:22-26, 1993.
  pubmed

• 61) Urban C, et al:Endocrine function after bone marrow transplantation without the use of preparative total body irradiation. Bone Marrow Transplantation 3:291-296, 1988.
  pubmed

• 62) Willi SM, et al:Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr 120:726-732, 1992.
  pubmed

• 63) Hartmann O, et al:Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumors. J Clin Oncol 2:1424-1425, 1984.
  pubmed

• 64) Spitzer G:Autotransplantation in solid tumors. Blood Rev 5:105-111, 1991.
  pubmed

• 65) Pinkerton R, et al:Autologous bone marrow transplantation in paediatric solid tumours. Clin Haematol 15:187-203, 1986.
  pubmed

• 66) Graham-Pole J, et al:High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Am J Pediatr Hematol Oncol 6:17-26, 1984.
  pubmed

• 67) Cornbleet MA, et al:Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 65:241-244, 1981.
  pubmed

• 68) McCann SR, et al:High-dose melphalan with autologous bone marrow transplantation in the treatment of metastatic Ewing's sarcoma. Ir J Med Sci 152:160-164, 1983.
  pubmed

• 69) Pick TE, et al:Autologous bone marrow transplantation in children. Crit Rev Oncol Hematol 8:311-337, 1988.
  pubmed

• 70) Dumontet C, et al:High dose chemotherapy with ABMT in soft tissue sarcomas:a report of 22 cases. Bone Marrow Translantaton 10:405-408, 1992.
  pubmed

• 71) Ekert H, et al:Experience with high dose multiagent chemotherapy and autologous bone marrow rescue in the treatment of twenty-two children with advanced tumours. Aust Paediatr J 20:195-201, 1984.
  pubmed

• 72) Philip T, et al:High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987.
  pubmed

• 73) Huijgens PC, et al:IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma. Hematol Oncol 9:245-251, 1991.
  pubmed

• 74) Freedman AS, et al:Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma:very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784-791, 1990.

• 75) Linch DC, et al:Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease:results of a BNLI randomised trial. Lancet 341:1051-1054, 1993.
  pubmed

• 76) Shoucheng Y, et al:The therapeutic and biological effects of total lymph node irradiation and autologous bone marrow infusion on malignant lymphoma patients. Clin Med Sci J 6:197-202, 1991.

• 77) Gordon BG, et al:Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood 80:2938-2942, 1992.
  pubmed

• 78) Rosenfeld CS, et al:Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease. Exp Hematol 19:317-321, 1991.

• 79) Petersen FB, et al:Autologous marrow transplantation for malignant lymphoma:a report of 101 cases from Seattle. J Clin Oncol 8:638-647, 1990.
  pubmed

• 80) Singer CR, et al:Clinical studies of ABMT in non-Hodgkin's lymphoma. Clin Hematol 15:105, 1986.

• 81) Chopra R, et al:Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma:a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 10:1690-1695, 1992.

• 82) Yau JC, et al:Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. Am J Hematol 41:40-44, 1992.
  pubmed

• 83) O'leary M, et al:Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. Am J Med 74:497-501, 1983.

• 84) Hartmann O, et al:high-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children:a phase II study. J Clin Oncol 4:1804-1810, 1986.
  pubmed

• 85) Yahalom J, et al:Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J Clin Oncol 11:1062-1070, 1993.
  pubmed

• 86) Sierra J, et al:Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission. Blood 81:1968-1976, 1993.
  pubmed

• 87) Bearman SI, et al:Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 7:1288-1294, 1989.
  pubmed

• 88) Harding M, et al:High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease. Eur J Cancer 28A:1396-1400, 1992.
  pubmed

• 89) Ghalie R, et al:Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas. Bone Marrow Transplantation 8:41-45, 1991.
  pubmed

• 90) Vaughan WP, et al:Early leukemia recurrence of non-Hodgkin lymphoma after high-dose antineoplastic therapy with autologous marrow rescue. Bone Marrow Transplantation 1:373-378, 1987.
  pubmed

• 91) 日本小児血液学会骨髄移植委員会:小児期骨髄移植全国集計 (1992). 日小血会誌 7:52-61, 1993.

• 92) 金子道夫ほか:厚生省班研究プロトコールによる進行神経芽腫の治療, 1993年3月集計の治療成績. 厚生省がん研究助成による研究報告集 神経芽腫 平成3/4年度研究報告, p205-209, 1993.

• 93) Shuster JJ, et al:The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J Clin Oncol 9:1045-1049, 1991.
  pubmed

• 94) Lanino E, et al:Did BMT change the clinical course of neuroblastoma? Bone Marrow Transplantation 7 (suppl 3):114-117, 1991.

• 95) Philip T, et al:High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma:an unselected group of stage IV patients over 1 year of age. J Clin Oncol 5:266-271, 1987.

• 96) Seeger RC, et al:Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 366:527-533, 1991.
  pubmed

• 97) 松山孝治:難治性小児がんと骨髄移植. 小児科診療 54:2584-2600, 1991.

• 98) Moss TJ, et al:Delayed surgery and bone marrow transplantation for widespread neuroblastoma. Ann Surg 206:514-520, 1987.
  pubmed

• 99) Dini G, et al:Bone marrow transplantation for neuroblastoma:a review of 509. Bone Marrow Transplantation 4 (supple 4):42-46, 1987.

• 100) Dini G, et al:Unpurged autologous bone marrow transplantation for neuroblastoma:the AIEOP-BMT group experience. Bone Marrow Transplantation 7 (suppl 3):109-111, 1991.

• 101) Philip T, et al:Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800mg/m2 to 1g 250/m2):a report from the LMCE group. Prog Clin Biol Res 271:573-582, 1988.

• 102) Emminger W, et al:Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity? Bone Marrow transplantation 8:119-123, 1991.
  pubmed

• 103) Kletzel M, et al:Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma. Med Pediatrt Oncol 20:64-67, 1992.
  pubmed

• 104) Kushner BH, et al:Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro. Med Pediat Oncol 18:454-458, 1990.

• 105) August CS, et al:treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609-616, 1984.
  pubmed

• 106) Pole JG, et al:High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma:a pediatric oncology group study. J Clin Oncol 9:152-158, 1991.

• 107) Corbett R, et al:[131I]Metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma. J Nucl Biol Med 35:228-231, 1991.
  pubmed

• 108) Stein J, et al:In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement:a pilot study. Prog Clin Biol Res 271:237-248, 1988.
  pubmed

• 109) Combaret V, et al:Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer 59:844-847, 1989.
  pubmed

• 110) Moss TJ, et al:Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991.
  pubmed

• 111) Garaventa A, et al:High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma. Eur J Cancer 29A:487-491, 1993.
  pubmed

• 112) G-Pole J, et al:Myeloablative chemoradiotherapy and autologous bone marrow infusions for treatment of neuroblastoma:factor influencing engraftment. Blood 78:1607-1614, 1991.

• 113) Ladenstein R, et al:Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma:a single centre analysis of prognostic factors. Eur J Cancer 29A:947-956, 1993.
  pubmed

• 114) Gordon SJ, et al:Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A:1319-1323, 1992.
  pubmed

• 115) Mugishima H, et a:Autotransplants in advanced neuroblastaoma. Cancer (in press).

• 116) Ikeda H, et al:Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory"Debulking"treatment. J Pediat Surg 27:1438-1441, 1992.
  pubmed

• 117) Englaro EE, et al:1-131 MIBG imaging after bone marrow transplantation for neuroblastoma. Radiol 182:515-520, 1992.

• 118) Corbett R, et al:Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A:1324-1328, 1992.
  pubmed

• 119) 大平睦郎:小児がんにおける自家骨髄移植, 並びに自家末梢血幹細胞移植に関する研究. 厚生省がん研究助成による研究報告集 平成3年度:341-346, 1993.

• 120)D' Angio GJ, et al:Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc):Results of a four-institution children's cancer study group pilot study. Prog Clin Biol Res 175:557-563, 1985.

• 121) Rajantie J, et al:Improved prognosis for children with stage IV neuroblastoma:high-dose melphalan and autologous unpurged marrow transplantation after aggressive surgery and short chemoterapy with cisplatinum and etoposide. Pediatrt Hematol Oncol 5:125-135, 1988.

• 122) Dopfer R, et al:Bone marrow transplantation in children with neuroblastoma. Folia Haematol 116:427-436, 1989.
  pubmed

• 123) Hartmann O, et al:Treatment of advanced neuroblastoma with two consecutive high-dose chemothera-py regimens and ABMT. Prog Clin Biol Res 175:565-568, 1985.

• 124) Hartmann O, et al:Repeat high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastic neuroblastoma. J Clin Oncol 5:1205-1211, 1987.

• 125) 河 敬世:神経芽細胞腫の自家骨髄移植. 今日の移植4 (supple 1):67-71, 1991.

• 126) Burdach S, et al:Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor pro-gnosis Ewing:s sarcoma. J CIin Oncol 11:1482-1488, 1993.

P.139 掲載の参考文献

• 1) 細谷亮太:小児白血病治療の倫理ならびに社会心理学的考察. 日小血会誌4:413-419, 1990.

• 2) 武田文和 (訳):末期癌患者の診療マニュアル, 第2版, 医学書院, 東京, pp9-41, 1991.

• 3) 細谷亮太:小児がん患者のターミナルケアとデスエデュケーション. ターミナルケア1:105-109, 1991.

• 4) Martinson IM, et al:Home care for children dying of cancer. Pediat 62:106-113, 1978.

• 5) 細谷亮太:小児がん患者の在宅ケア. (I) (II) 平成3年及び4年度厚生省心身障害研究「市町村母子保健活動の効率化に関する研究班」分担研究. 小児慢性特定疾患児の在宅ケアに関する研究報告書, pp32-39, 61-67.

• 6) 真部 淳ほか:小児がん患児における完全埋め込み式中心静脈確保システムの使用経験. 小児科31 (1):113-115, 1990.

IV. 治療各論

P.158 掲載の参考文献

• 1) 脳腫瘍全国統計委員会:脳腫瘍全国集計調査報告Vol. 8, 1993.

• 2) McLone DG:Cerebellar astrocytomas. In Neurosurgery, ed. by Wilkins, RH&Rengachary SS, pp754-757, McGraw-Hill Book Company, 1985.

• 3) Ilgren EB, Stiller CA:Cerebellar astrocytomas. Clinical characteristics and prognostic indicies. JNeuro-Onco 4:293-308, 1987.

• 4) Davis CH, Joglekar VM:Cerebellar astrocytomas in childten and young adults. J Neurol Neurosurg Psychiatry 44:820-828, 1981.

• 5) Undjian S, Marinov M, Georgiev K:Long-term follow-up after surgical treatment of cerebellar astrocytomas in 100 children. Child's Nerv Syst 5:99-101, 1989.

• 6) 星野孝夫:Gliomaの増殖能. 神経進歩31:1023-1029, 1987.

• 7) Pasqualini T, Diez E, Domene H, et al:Long-term endocrine sequelae after surgery, radiotherapy and chemotherapy in children with medulloblastoma. Cancer 59:801-806, 1987.

• 8) Silverman CL, Palker H, Talent B, et al:Late effects of radiotherapy on patients with cerebellar medulloblastoma. Cancer 54:825-829, 1984.

• 9) Vijayakumar S, Muller-Runkle R:Medulloblastoma:Are we overtreating? J Natl Med Ass 77:89-95, 1985.

• 10) Brand WN Schneider PA, Tokars RP:Long term results of a pilot study of low dose cranial-spinal radiation for cerebellar medulloblastoma. Int J Radiat Oncol Biol Phys 12 (suppl 1):144-145, 1986.

• 11) Van Eys J, Cangir A, Coody D, et al:MOPP regimen as primary chemotherapy for brain tumors in infants. J Neuro-Oncol 3:237-243, 1985.

• 12) Crafts DC, Levin VA, Edwards MS:Chemotherapy of recurrent medulloblastoma with combined pro-carbazine, CCNU, and vincristine. J Neurosurg 49:589-592, 1978.

• 13) Duffner PK, Cohen ME, Thomas PRM:Combination Chemotherapy in recurrent medulloblastoma. Cancer 43:41-45, 1979.

• 14) Seiler RW:Combination chemotherapy with VM26 and CCNU in primary malignant brain tumors of children. Helv Pediat Acta 35:51-56, 1980.

• 15) Cangir A, Van Eyes J, Steubner P:Combination chemotherapy with vincristine, procarbazine, predonisone with or without nitrogen mustard (MOOP vs OPP) in children with recurrent brain tumors. Med Ped Oncol 12:1-3, 1984.

• 16) Levin VA, Shelin GE, Gutin PH:Neoplasmas of the central nervous system, Medulloblastoma. In Cancer-Principles&Practice of Oncology (3rd ed.), ed. by DeVita VT, Hellman S, Rosengerg SA, pp 1595-1597, JB Lippincott Co, 1989.

• 17) Freidman HS, Mahaley MS, Schold SC Jr:The efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery 18:335-340, 1986.

• 18) Thomas PR, Duffner PK, Cohen ME:Multimodality therapy for medulloblastoma. Cancer 45:666, 1980.
  pubmed

• 19) 岡本 裕, 清水恵司, 宮尾泰慶ほか:Medulloblastoma患老に対するallogenic LAK細胞を用いた養子免疫療法. 医学のあゆみ140:833-834, 1987.

• 20) 倉津純一, 高木修一, 三原洋祐ほか:ヌードマウス移植ヒト髄芽腫細胞に対するヒト線維芽細胞インターフェロンの抗腫瘍効果. 医学のあゆみ150:169-170, 1989.

• 21) Bloom HJG:Treatment of brain gliomas in children. In Tumors of the Brain, ed. by Bleehen NM, pp121-140, Springer-Verlag, Berlyn, Heiderberg, New York, Tokyo, 1986.

• 22) Marks JE, Gado M:Serial computed tomography of primary brain tumors following surgery, irradiation, and chemotherapy. Radiology 125:119-125, 1977.
  pubmed

• 23) 根来 真, 小林達也, 影山直樹ほか:Brain stem gliomaに対するCT scan及びmetrizamide CT cisternographyの有用性. CT研究2:213-219, 1980.

• 24) Baghai P, Vries JK, Bechtel PC:Retromastoid approach for biopsy of brain stem tumors. Neurosurgery 10:574-579, 1982.
  pubmed

• 25) Reigel DH, Scarff TB, Woodford JE:Biopsy of pediatric brain stem tumors. Child's Brain 5:329-340, 1979.
  pubmed

• 26) Hoffman HJ, Becker L, Craven MA:A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 65:172-176, 1986.

• 27) Nishio S, Fukui M, Tateishi J:Brain stem gliomas. A clinicopathological analysis of 23 histologically proven cases. J Neuro-Oncology 6:245-250, 1988.

• 28) Albright AJ, Guthkelch AN, Packer RJ, et al:Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 65:751-755, 1986.

• 29) Epstein F:A staging system for brain stem gliomas. Cancer 56:1804-1806, 1985.
  pubmed

• 30) Epstein F, McCleary EL:Intrinsic brain-stem tumors of childhood:Surgical indications. J Neurosurg 64:11-15, 1986.
  pubmed

• 31) Epstein F, Wisoff J:Intra-axial tumors of the cervicomedullary junction. J Neurosurg 67:483-487, 1987.
  pubmed

• 32) Thomas DGT, Bradford R, Gill S, et al:Computer-directed stereotactic biopsy of intrinsic brain stem lesions. Br J Neurosurg 2:235-240, 1988.

• 33) Villani R, Gaini SM, Tomei G:Follow-up study of brain stem tumors in children. Child's Brain 1:126-135, 1975.
  pubmed

• 34) Albright AL, Price RA, Guthkelch AN:Brain stem gliomas of children. A clinicopathologic study. Cancer 52:2313-2319, 1983.
  pubmed

• 35) Grigsby PW, Thomas PRM, Schwartz, HG, et al:Irradiation of primary thelamic and brain-stem tumors in a pediatric population. A 33-year experience. Cancer 60:2901-2906, 1987.

• 36) Lee BCP, Kneeland JB, Walker RW, et al:MR imaging of brain stem tumors. AJNR 6:159-163, 1985.

• 37) Edwards MSB, Wara WM, Urtrasun RC, et al:Hyperfractionated radiation therapy for brain-stem glioma:A phase I-II trial. J Neurosurg 70:691-700, 1989.

• 38) Rodriguez LA, Prados M, Filton D, et al:Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine. Neurosurgery 22:691-693, 1988.

• 39) 伊藤治英, 長谷川健, 正印克夫ほか:脳幹神経膠腫における壊死巣摘出と抗腫瘍剤局所投与. 脳神経外科 13:1053-1057, 1985.

• 40) 鬼頭 晃, 吉田純, 影山直樹:Brain stem gliomaに対する最近の治療方針と治療成績. 脳神経外科15:797-803, 1987.

• 41) Takahashi H, Herlyn D, Atkinson B, et al:Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res 47:3847-3850, 1987.
  pubmed

• 42) 高橋 弘, 足立好司, 中沢省三ほか:悪性グリオーマに対するモノクローナル抗体を用いたミサイル療法の試み. 神経免疫研究5:241-244, 1992.

• 43) 松谷雅生, 佐野圭司:Brain stem gliomaの治療と予後. 小児の脳神経2:411-416, 1978.

• 44) Tomita T, McLone DG, Naidich TP:Brain stem gliomas in childhood:Rational approach and treatment. J Neuro-Oncol 2:117-122, 1984.

• 45) Freeman CR, Suissa S:Brain stem tumors in children:Result of a survey of 62 patients treated withradiotherapy. Int Radiation Oncol Biol Phys 12:1823-1828, 1986.
  pubmed

• 46) Grigsby PW, Thomas PR, Schwartz HG, et al:Multivariate analysis of prognostic factors in pediatric and adult thalamic and brainstem tumors. Int J Radiat Oncol Biol Phys 16:649-655, 1989.
  pubmed

• 47) Miller JH, Pena AM, Segall HD:Radiological investigation of sellar region masses in children. Radiology l 34:81-87, 1980.

• 48) Hoffman HJ, Hendric EB, Humphreys RP, et al:Management of craniopharyngioma in children. J Neurosurg 47:218-227, 1977.

• 49) Amacher L:craniopharyngioma:The contoversy regarding radiotherapy. Child's Brain 6:57-64, 1980.

• 50) Vyramuthu N, Benton TF:The management of craniopharyngioma. Clinic Radiol 34:629-632, 1983.

• 51) Richmond IL, Wara WM, Wilson CB:Role of radiation therapy in the management of craniopharyngiomas in children. Neurosurgery 6:163-168, 1978.

• 52) Shapiro K, Till K, Grant DR:Craniopharyngiomas in childhood. A rational approach to treatment. J Neurosurg 50:617-623, 1979.

• 53) Sung DI, Chang CH, Harisiadis L, et al:Treatment results of craniopharyngiomas. Cancer 47:847-852, 1981.

• 54) Barrow DL, Spector RH, Takei Y, et al:Symptomatic Rathke's cleft cysts located entirely in the suprasellar region:Review of diagnosis management and pathogenesis. Neurosurgery 16:766-772, 1985.
  pubmed

• 55) Katz EL:Late results of radical excision of craniopharyngioma in children. J Neurosurg 42:86-90, 1975.

• 56) Kobayashi T, Kageyama N, Ohara K:Intemal irradiation for cystic craniopharyngioma. J Neurosurg 55:896-903, 1981.

• 57) Pollack IF, Lunsford LD, Slamovits TL, et al:Stereotaxic intracavitary irradiation for cystic craniopharyngiomas. J Neurosurg 68:227-233, 1988.
  pubmed

• 58) Bremer AM, Nguyen TQ, Balsys R:Therapeutic benefits of combination chemotherapy with vin-cristine, BCNU and procarbazine on recurrent cystic craniopharyngioma. A case report. J Neuro-Oncol 2:47-51, 1984.

• 59) Takahashi H, Nakazawa S, Shimura T:Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 62:120-127, 1985.

• 60) Hoff JT, Patterson RH:Craniopharyngiomas in children and adults. J Neurosurg 36:299-302, 1972.
  pubmed

• 61) Till K:Craniopharyngioma. Child's Brain 9:179-187, 1982.

• 62) Allen JC, Kim JH, Packer RJ:Neoadjuvant chemotherapy for newly diagnosed CNS germ cell tumors. JNeurosurg 67:65-70, 1987.
  pubmed

P.175 掲載の参考文献

• 1) 金子明博:日本の1975-1979年における網膜芽細胞腫の発生頻度に関する調査報告. あたらしい眼科1:137-138, 1984.

• 2) Kaneko A:Clinical aspects of retinoblastoma in Japan, In; Takebe H, Utsunomiya J (ed), Gann Monogr. Cancer Res 35:Genetics of Human Tumor in Japan, Japan Scienific Societies Press, p29-34, 1988.

• 3) 網膜芽細胞腫全国登録委員会:網膜芽細胞腫 (1975-1982):日眼会誌96:1433-1442, 1992.

• 4) 金子明博:涙腺癌の治療. あたらしい眼科8:23-26, 1991.

• 5) 金子明博, 築山 巌:眼球内網膜芽細胞腫に対する放射線外照射後の再発に関する検討. 小児がん25:152-154, 1989.

• 6) 金子明博, 築山 巌:眼 眼窩の腫瘍, 放射線医学体系31巻, 中山書店, p285-309, 1987.

• 7) 金子明博:温熱療法を使用した網膜芽細胞腫の眼球保存療法. CRC 2:178-183, 1993.

• 8) 高山 順:眼科腫瘍, 今日の小児治療指針, 第10版, p461-462, 1993.

• 9) Roarty MD, et al:Incidence of second neoplasms in patients with bilateral retinoblastoma, Ophthalmology 95:1583-1587, 1988.

• 10) Matsunaga E:Recurrence risks to relatives of patients with retinoblastoma. JPn J Ophthalmol 22:313-319, 1978.

• 11) 金子行子ほか:胎児眼球の超音波診断について. 臨眼46:279-282, 1992.

P.191 掲載の参考文献

• 1) Sawada T, et al:Med Pediatr Oncol 12:101-103, 1984.

• 2) Brodeur GM, et al:J Clin Oncol 11:1466-1477, 1993.
  pubmed

• 3) 太田 茂ほか:小児外科24:143-150, 1992.

• 4) Berthold F:Overview:Biology of neuroblastoma. in neuroblastoma:TUMOR BIOLOGY and THERAPY (ed. by Pochedly C), p1-27, CRC Press, Boston, 1990.

• 5) Seeger RC, et al:New Engl J Med 313:1111-1116, 1985.
  pubmed

• 6) Look AT, et al:J Clin Oncol 9:581-591, 1990.

• 7) Tanaka T, et al:Cancer 68:1296-1302, 1991.
  pubmed

• 8) Nakagawara A, et al:New Engl J Med 328:847-854, 1993.
  pubmed

• 9) Fong C, et al:Cancer Res 52:1780-1785, 1992.
  pubmed

• 10) Caron H, et al:New Engl J Med 334:225-230, 1996.
  pubmed

• 11) Chan HSL, et al:New Engl J Med 325:1608-1614, 1991.

• 12) Bordow SB, et al:Cancer Res 54:5036-5040, 1994.
  pubmed

• 13) Brodeur GM:小児がん 30:839-844, 1993.

• 14) 四方卓磨ほか:日小外会誌30:261-272, 1994.

• 15) Sawaguchi S, et al:Cancer 66:1879-1887, 1990.
  pubmed

• 16) 金子道夫ほか:小児がん 32:271, 1995.

• 17) Haase GM, et al:J Pediatr Surg 30:289-295, 1995.
  pubmed

• 18) Ohnuma N, et al:Med Pediatr Oncol 24:181-187, 1995.
  pubmed

• 19) 江口春彦:日常診療と血液5:627-630, 1995.

• 20) Matthay KK, et al:JCIin Oncol 11:2226-2233, 1993.
  pubmed

• 21) 澤田 淳ほか:厚生省がん研究助成金による研究報告書「分子細胞遺伝学的情報からみた神経芽細胞腫の集学的治療に関する研究」p171-176, 平成5年7月.

P.208 掲載の参考文献

• 1) 全国骨腫瘍患者登録一覧表 (平成2年度):国立がんセンター.

• 2) Ewing J:Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17-24, 1921.

• 3) 牛込新一郎, 高桑俊文:ユーイング肉腫をめぐる最近の知見. 病理の臨床7:93-98, 1989.

• 4) Angervall L, Enzinger FM:Extrasketal neoplasm resembling Ewing's sarcoma. Cancer 36:240-251, 1975.
  pubmed

• 5) Stout AP:A tumor of the ulnar nerve. Proc NY Acad Soc 18:2-12, 1918.

• 6) Jaffe R, Santamana M, Yunis EJ, et al:The neuroectodermal tumor of bone. Am J Surg Pathol 8:885-898, 1984.

• 7) Miller RW:Geographical and ethnic differences in the occurrence of childhood cancer. International incidence of childhood cancer, Parkin DM, et al, 1st ed International agent for reseach on cancer Lyon p3-7, 1988.

• 8) Hirayama T:Descriptive and analytical epidemiology of childhood malignancy in Japan. Recent advances in managements of children with cancer, Kobayashi N 1st ed The children's cancer association of Japan Tokyo, p27-43, 1980.

• 9) Jurgens H, Bier V, Harms D, et al:Malignant peripheral neuroectodermal tumors:Aretrospective analysis of 42 patients. Cancer 61:349-357, 1988.

• 10) Kissane JM, Askin FB, Foulkes M, et al:Ewing's sarcoma of bone:Clinicopathologic aspects of 303 cases from the Intergroup Ewing's sarcoma study. Hum Pathol 14:773-779, 1983.
  pubmed

• 11) Nakissa N, Constine LS, Rubin P, et al:Birth defects in three common pediatric malignancies; Wilms's tumor, Neuroblastoma and Ewing's sarcoma. Oncology 42:358-363, 1985.

• 12) McKeen EA, Hanson MR, Mulvihill JJ, et al:Birth defects with Ewing's sarcoma. N Engl J Med 309:1522, 1983.
  pubmed

• 13) Sneppen O, Hansen LM:Presenting symptoms and treatment delay osteosarcoma and Ewing's sarcoma. Acta Radiol Oncol 23:159-162, 1984.
  pubmed

• 14) 秦 順一:小児固形腫瘍, 特に「小円形細胞腫瘍群」の形態学的特徴と鑑別診断. 小児がん 27:555-560, 1990.

• 15) 牛込新一郎, 千葉 論:ユーイング肉腫とその鑑別. 取扱い規約に沿った腫瘍鑑別診断アトラス骨, 町並陸生他編, 第1版, p139-147, 文光堂, 東京, 1992.

• 16) Dickman PS, Triche TJ:Extraosseous Ewing's sarcoma versus primitive rhabdomyosarcoma:diagnostic criteria and clinical correlation. Hum Pathol 17:881-893, 1986.
  pubmed

• 17) Horowitz ME, Malawer MM, Delaney TF, et al:Ewing's sarcoma family of tumors:Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. Principle and practice of pediatric oncology, Pizzo PA, et al 2nd ed Lippincott JB Philadelphia, p795-821, 1993.

• 18) Schmidt D, Herrmann C, Jurgens H, et al:Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma:A report from the Kiel pediatric tumor registry. Cancer 68:2251-2259, 1991.
  pubmed

• 19) Marina NM, Etcubanas E, Parham D, et al:Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children:A review of the St. Jude experience and controversies in diagnosis and management. Cancer 64:1952-1960, 1989.
  pubmed

• 20) Hamilton G, Fellinger EJ, Schratter I, et al:Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. Cancer Res 48:6127-6134, 1988.
  pubmed

• 21) Hara S, Ishii E, Yokoyama J, et al:A monoclonal antibody specifically reactive with Ewing's sarcoma. Br J Cancer 60:875-879, 1989.
  pubmed

• 22) 原 眞一, 八反田洋一, 秦 順一ほか:Ewing肉腫とPNET, 小児外科24:204-211, 1992.

• 23) Turc-Carel C, Aurias A, Mugneret F, et al:Chromosomes in Ewing's sarcoma:I An evaluation of 85 cases and remarkable consistency of t (11; 22) (q24; q12):Cancer Genet Cytogenet 32:229-238, 1988.
  pubmed

• 24) Becroft DMO, Pearson A, Shaw RL, et al:Chromosome translocation extraskeletal Ewing's tumour. Lancet ii:440, 1984.

• 25) Delattre O, Zucmann J, Plougastel B, et al:Cloning of the recurrent t (11; 22) translocation of Ewing's sarcoma & peripheral neuroepithelioma. Proc AACR 33:604, 1992.

• 26) Delattre O, Zucmann J, Plougastel B, et al:Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162-165, 1992.

• 27) Yee D, Favoni RE, Lebovic GS et al:Insulin-1ike growth factor I expression by tumors of neuroectodermal origin with the t (11; 22) chromosomal translocation. A potential autocrine growth factor. J Clin Invest 86:1806-1814, 1990.

• 28) McKeon C, Thiele CJ, Ross RA, et al:Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors:Ewing's sarcoma and neuroepithelioma. Cancer Res 48:4307-4311, 1998.

• 29) Bechet JW, Bornkamm G, Freese UK, et al:The c-sis oncogene is not activated in Ewing's sarcoma. N Engl J Med 310:393, 1984.

• 30) Douglass EC, Rowe ST, Valentine M, et al:A second nonrandom translocation, der (16) t (1; 16) (q21; q31), in Ewing sarcoma and peripheralneuroectoderrnal tumor. Cytogenet Cell Genet 53:87-90, 1990.

• 31) Mulligan LM, Matlashewski GJ, Scrable HJ, et al:Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87:5863-5867, 1990.
  pubmed

• 32) Sheng WW, Jacobs D, Soukups, et al:Compalison of chromosome analysis to DNA content by flow cytometry for pediatric tumors. Pediatr Pathol 10:671-679, 1990.
  pubmed

• 33) Williams MP, Husband JE, McElwain TJ:Role of computed tomography scanning in the management of Ewing's sarcoma. Med Pediatric Oncol 17:414-417, 1989.

• 34) Holscher HC, Bloem JL, Nooy MA, et al:The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR 154:763-769, 1990.

• 35) Lemmi MA, Fletcher BD, Marina NM, et al:Use of MR imaging to assess results of chemotherapy for Ewing's sarcoma. AJR 155:343-346, 1990.

• 36) Nesbit ME, Gerhan EA, Burgert EO, et al:Multimodel therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone:Along-term follow-up of the first intergroup study. J Clin Oncol 8:1664-1674, 1990.

• 37) Burgert EO, Nesbit ME, Gamsey LA, et al:Multimodel therapy for the management of nonpelvic, localized Ewing's sarcoma of bone:Intergroup study IESS-II. J Clin Oncol 8:1514-1524, 1990.

• 38) Evans RG, Nesbit ME, Gehan EA, et al:Multimodel therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones:A report from the second intergroup study. J Clin Oncol 9:1173-1180, 1991.

• 39) Cangir A, Vietti TJ, Gehan EA, et al:Ewing's sarcoma metastatic at diagnosis:Results and comparisons of two Intergroup Ewing's sarcoma studies. Cancer 66:887-893, 1990.
  pubmed

• 40) Donaldson S, Shuster J Andreozzi C, et al:The Pediatric Oncology Group (POG) experience in Ewing's sarcopna of bone. Med Pediatr Oncol (Abst) 17:283, 1989.

• 41) Jurgens H, Exner U, Gadner H, et al:Multidisciplinary treatment of primary Ewing's sarcoma of bone:A 6-year experience of a European cooperative trial. Cancer 61:23-32, 1988.

• 42) Dunst J, Sauer R, Burgers JMV, et al:Radiation therapy as local treatment in Ewing's sarcoma. Cancer 67:2818-2825, 1991.

• 43) Miser JS, Kinsella TJ, Triche TJ, et al:Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults:six months of intensive combined modality therapy without maintenance. J Clin Oncol 6:484-490, 1988.

• 44) Hayes FA, Thompson EI, Meyer WH, et al:Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 7:208-213, 1989.

• 45) Hayes FA, Thompson EI, Kumar M, et al:Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy. Med Pediatr Oncol 15:254-256, 1987.
  pubmed

• 46) Meyer WH, Kun L, Marina N, et al:Ifosfa mide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 10:1737-1742, 1992.

• 47) Oberlin O, Habrand JL, Zucker JM, et al:No benefit of Ifosfamide in Ewing's sarcoma:A nonrandomized study of the French society of pediatric oncology. J Clin Oncol 10:1407-1412, 1992.
  pubmed

• 48) 別府保男:骨悪性腫瘍の治療の進歩. 小児科診療 52:224-234, 1989.

• 49) 立石昭夫:骨・軟部腫瘍. 最新医学46:1464-1469, 1991.

• 50) 山崎慎也:悪性骨腫瘍化学療法の実際. 日整会誌66:126-136, 1992.

• 51) Trigg ME, Makuch R, Glaubiger D:Actuarial risk of isolated CNS involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexate. Int J Radiation Oncol Biol Phys 11:699-702, 1985.

• 52) Horowitz ME, Neff JR, Kun LE:Ewing's sarcoma:radiotherapy versus surgery for local control . Pediatric Clin North America 38:365-380, 1991.

• 53) Kushner BH, Hajdu SI, Gulati SC, et al:Extracranial primitive neuroectodermal tumors:The memorial Sloan-Kettering cancer center experience. Cancer 67:1825-1829, 1991.
  pubmed

• 54) Kung FH, Pratt CB, Vega RA, et al:Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood:A pediatric oncology group phase II study. Cancer 71:1898-1902, 1993.
  pubmed

• 55) 川井 章, 別府保男, 横山良平ほか:悪性骨・軟部腫瘍に対するifosfamideを中心とした化学療法. 整形外科44:883-889, 1993.

• 56) Miser JS, Kinsella TJ, Triche TJ, et al:Ifosfamide with mesna uroprotection and etoposide:An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191-1198, 1987.

• 57) Lokich J, Anderson N, Zipoli T, et al:Ifosfamide infusion without mesna:prolongation of infusion duration to minimize neurologic and urologic toxicity. Proc ASCO (Abst) 9:89, 1990.

• 58) 石井 猛, 梅田 透, 鬼頭正士ほか:骨軟部肉腫に対するIfosfamide療法の副作用の検討. 癌と化学療法20:509-513, 1993.

• 59) Seeger RC, Reynolds CP:Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatric Clin North America 38:393-424, 1991.

• 60) 大平睦郎:小児がんの治療における自家骨髄移植. 小児がん28:687-692, 1992.

• 61) Estes DN, Magill HL, Thompson EI, et al:Primary Ewing sarcoma:follow-up with 67-Ga scinigraphy. Radiology 177:449-453, 1990.

• 62) Daugaard S, Kamby C, Sunde LM, et al:Ewing's sarcoma:A retrospective study of histlogical and immunohistochemical factors and their relation to prognosis. Virchows Archiv A Pathol Anat 414:243-251, 1989.

• 63) Nicholson HS, Mulvihill JI, Byme J:Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatric Oncol 20:6-12, 1992.

• 64) Askin FB, Rosai J, Sibley RK, et al:Malignant small cell tumor of the thoracopulmonary region in childhood. Cancer 43:2438-2451, 1979.
  pubmed

• 65) 高桑俊文:Askin腫瘍とその組織発生. 小児外科24:211-215, 1992.

• 66) Linnoila RI, Tsdokos M, Triche TJ, et al:Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor"):Am J Surg Pathol 10:124-133, 1986.

• 67) Shamberger RC, Grier HE, Weinstein HJ, et al:Chest wall tumors in infancy and childhood. Cancer 63:774-785, 1989.
  pubmed

• 68) Parikh PM, Charak BS, B, Banavali SD, et al:Treatment of Askin Rosai tumor-need for a more aggressive approach. J Surg Oncology 39:126-128, 1988.

• 69) Young MM, Kinsella TJ, Miser JS, et al:Treatment of sarcomas of the chest wall using intensive combined modality therapy. Int J Radiat Oncol Biol Phys 16:49-57, 1989.
  pubmed

• 70) Barr FG, Chatten J, D'Cruz CM, et al:Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 15:553-557, 1995.

P.227 掲載の参考文献

• 1) Crist WM, et al:Prognosis in children with rhabdomyosarcoma:a report of the Intergroup Rhab-domyosarcoma Studies I and II. J Clin Oncol 8:443-452, 1990.

• 2) Newton WA Jr.:Sarcomas of children:current status and challenges. 小児がん29:7-23, 1993.

• 3) Maurer HM, et al:Rhadomyosaucoma, in Fernbach DJ, et al (eds):Clinical Pediatric Oncology, St. Louis, Mosby, 491-515, 1991.

• 4) 小児がん全国登録委員会・登録関係委員会:日本小児がん全国登録-データベースを如何に活用するか-. 癌の臨床35:239-247, 1989.

• 5) Maurer MH, et al:the intergroup rabdopmyosarcoma study-I a final report. Cancer 61:209-220, 1988.

• 6) Raney RB Jr.:Rhabdomyosarcoma and undifferentiated sarcomas, in Pizzo PA, et al (eds):Principle and Practice of Pediatric Oncology. Philadelphia, JB Lippincott, pp769-794, 1993.

• 7) 原 純一ほか:von-Recklinghausen病に合併した腔原発の横紋筋肉腫の1例. 小児科臨床 36:1466-1470, 1983.

• 8) Li FP, et al:Soft tissue sarcomas, breast cancer, and other neoplasms. a familial syndrome? Ann Intern Med 71:747-752, 1969.
  pubmed

• 9) Shapiro DN, et al:Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53:5108-5112, 1993.
  pubmed

• 10) Newton WA Jr, et al:Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma studies I and II:clinicopathologic correlation. J Clin Oncol 6:67-75, 1988.
  pubmed

• 11) Rodary C, et al:Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis. Med Pediatr Oncol 16:71-77, 1988.
  pubmed

• 12) 石田也寸志ほか:小児横紋筋肉腫80例の臨床的検討-第一編:臨床像について-日児誌 94:1196-1200, 1990.

• 13) 多和昭雄ほか:小児横紋筋肉腫37例の治療成績日児誌 98:1206-1211, 1994.

• 14) Quddus FF, et al:Comparison between X-ray and bone scan detection of bone metastases in patients with rhabdomyosarcoma. Med Pediatr Oncol 11:125-129, 1983.
  pubmed

• 15) 日本病理学会小児腫瘍組織分類委員会:小児腫瘍組織分類 第2篇 軟部組織腫瘍 東京, 金原出版, 1976.

• 16) 石田也寸志ほか:小児横紋筋肉腫80例の臨床的検討-第2編:予後因子について-日児誌 94:1201-1206, 1990.

• 17) Hays DM, et al:Primary reexcission for patients with 'microscopic residual' tumor following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 24:5-10, 1989.

• 18) Hays DM, et al:Secondary surgical procedure to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas:a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 25:1100-1105, 1990.
  pubmed

• 19) Green DM:The treatment of advanced or recurrent malignant genitourinary tumors in children. Callcer 60:602-611, 1987.

• 20) Mandell LR, et al:Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rabdomyosarcoma (RMS):Int J Radiation Oncology Biol Phys 15:197-203, 1988.

• 21) Wilbur JR:Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep 58:281-284, 1974.
  pubmed

• 22) Bode U:Methotrexate as relapse therapy for rhabdomyosarcoma. Am J Pediatr Hematol Oncol 8:70-72, 1986.
  pubmed

• 23) Miser JS, et al:Ifosfamide with mesna uroprotection and etoposide:an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191-1198, 1987.

• 24) 多和昭雄ほか:Vinblastine, Cis-platinum, Bleomycinの3剤併用療法が著効を示した膀胱原発横紋筋肉腫の1例. 癌と化学療法9:2222-2228, 1982.

• 25) Raney RBJr:Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma. Cancer Treat Rep 71:407-408, 1987.
  pubmed

• 26) Crist WM, et al:Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas. Med Pediatr Oncol 15:51-57, 1987.

• 27) Horowitz ME, et al:Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma:a model for anticancer drug development. J Clin Oncol 6:308-314, 1988.

• 28) Maurer HM, et al:The intergroup rhabdomyosarcoma study-II. Cancer 71:1904-1922, 1993.
  pubmed

• 29) Crist W, et al:The third lntergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995.
  pubmed

• 30) 野崎千佳ほか:小児横紋筋肉腫22例の検討. 小児がん32:439-443, 1995.

• 31) 大平睦郎:自家幹細胞移植による小児がん治療の現況. 日小血会誌8:2-11, 1994.

• 32) Kinsella TJ, et al:Treatment of high-risk sarcomas in children and young adults; analysis of local control using intensive combined modality therapy. NCI Monogr 6:291-296, 1988.

• 33) Dumontet C, et al:High dose chemotherapy With ABMT in soft tissue sarcomas:areport of 22 cases. Bone Marrow Transplant 10:405-408, 1992.

• 34) 高山 順ほか:小児横紋筋肉腫に対する骨髄移植. 小児外科26:61-66, 1994.

• 35) 日本小児血液学会骨髄移植委員会:小児期骨髄移植全国集計 (1995):日小血会誌10:29-41, 1996,

• 36) Raney RBJr, et al:Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. Cancer 59:147-155, 1987.

• 37) Raney RBJr, et al:Paratesticular sarcoma in childhood and adolescence:a report from the intergroup rhabdomyosarcoma studies I and II, 1973-1983. Cancer 60:2337-2343, 1987,

• 38) Heyn R, et al:Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma:a report from the intergroup rhabdomyosarcoma study. J Clin Oncol 7:200-207, 1989.
  pubmed

• 39) Raney RBJr, et al:Soft-tissue sarcoma of the trunk in childhood:results of the intergroup rhabdomyosarcoma study. Cancer 49:2612-2616, 1982.

• 40) Crist WM, et al:Soft-tissue sarcoma arising in the retroperitoneal space in children:a report from the intergroup rhabdomyosarcoma study (IRS) committee. Cancer 56:2125-2132, 1982.

• 41) Ragab AH, et al:Infants younger than 1 year of age with rhabdomyosarcoma. Cancer 58:2606-2610, 1986.
  pubmed

• 42) Tefft M, et al:Radiation therapy in embryonal rhabdomyosarcoma (ERS):local control (LC) in children less than one year of age and in children With tumors of the orbit. A report from The Intergroup Rhabdomyosarcoma Committee (IRS):Proc Am Soc Clin Oncol 5:205, 1986.

P.244 掲載の参考文献

• 1) 全国骨腫瘍患者登録一覧表 (昭和62年度). 日本整形外科学会骨軟部腫瘍委員会, 国立がんセンター編, p 109, 1987.

• 2) Schajowicz F, Sissons HA, Sobin LH:The World Health Organization's histologic classification of bone tumors:a commentary on the second edition. Cancer 75:1208-1214, 1995.
  pubmed

• 3) Enneking WF, Spanier SS, Goodman MA:A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-120, 1980.
  pubmed

• 4) Taylor WF, Ivins JC, Pritchard DJ, et al:Trends and variability in survival among patients with osteosarcoma:a 7-year update. Mayo Clin Proc 60:91-104, 1985.
  pubmed

• 5) Taylor WF, IVins JC, Unni KK, et al:Prognostic variables in osteosarcoma:a Multi-Institutional Study. J Natl Cancer Inst 81:21-30, 1989.
  pubmed

• 6) Edmonson JH, Green SJ, Ivins JC, et al:A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2:152-156, 1984.
  pubmed

• 7) Eilber F, Giuliano A, Eckardt J, et al:Adjuvant chemotherapy for osteosarcoma:a randomized prospective trial. J Clin Oncol 5:21-26, 1987.

• 8) Link MP, Goorin AM, Miser AW, et al:The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1606, 1986.
  pubmed

• 9) Link MP, Goorin AM, Horowitz M, et al:Adjuvant chemotherapy of high-grade osteosarcoma of the expremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Onthop 270:8-14, 1991.
  pubmed

• 10) Rosen G, Murphy ML, Huvos AG, et al:Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteosarcoma. Cancer 37:1-11, 1976.
  pubmed

• 11) Rosen G, Marcove RC, Caparros B, et al:Primary osteogenic sarcoma:The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2177, 1979.
  pubmed

• 12) Rosen G, Caparros B, Huvos AG, et al:Preoperative chemotherapy for osteogenic sarcoma:selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230, 1982.
  pubmed

• 13) Rosen G:Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma:a ten year experience. Orthopedics 8:659-664, 1985.

• 14) Meyers PA, Heller G, Healey J, et al:Chemotherapy for nonmetastatic osteogenic sarcoma:the Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
  pubmed

• 15) Jaffe N, Frei, III E, Traggis D, et al:Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 291:994-997, 1974.

• 16) Cortes EP, Holland JF, Wang JJ, et al:Amputation and adriamycin in primary osteosarcoma. N Engl J Med 291:998-1000, 1974.
  pubmed

• 17) Cortes EP, Holland JF, Glidewell O:Amputation and adriamycin in primary osteosarcoma:a 5-year report. Cancer Treat Rep 62:271-277, 1978.
  pubmed

• 18) Ochs JJ, Freeman AI, Douglass HO, et al:Cisdichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62:239-245, 1978.

• 19) Ettinger LJ, Douglass Jr HO, Higby DJ, et al:Adjuvant adriamycin and cisdiamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer 47:248-254, 1981.

• 20) Ettinger LJ, Douglass Jr HO, Mindel ER, et al:Adjuvant adriamycin and cisplatin in newly diagnosed, nonmetastatic osteosarcoma of the extremity. J Clin Oncol 4:353-362, 1986.

• 21) Sutow WW, Sullivan MP, Fernbach DJ, et al:Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study. Cancer 36:1598-1602, 1975.

• 22) Sutow WW, Gehan EA, Dyment PG, et al:Multidrug adjuvant chemotherapy for osteosarcoma:interim report of the Southwest Oncology Group studies. Cancer Treat Rep 62:265-269, 1978.

• 23) Medical Research Council:A trial of chemotherapy in patients with osteosarcoma (a report of the Medical Research Council by their working party on bone sarcoma). Br J Cancer 53:513-518, 1986.

• 24) Burgers JMV, van Glabbeke M, Busson A, et al:Osteosarcoma of the limbs. Report of the EORTCSIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation. Cancer 61:1024-1031, 1988.
  pubmed

• 25) Pratt CB, Champion JE, Fleming ID, et al:Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive protocol studies. Cancer 65:439-445, 1990.
  pubmed

• 26) Meyers PA, Heller G, Healey J, et al:Chemotherapy for nonmetastatic osteogenic sarcoma:the Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
  pubmed

• 27) 佐々木邦明, 村上正, 松岡初文ほか:Methotrexateとcis-platinumの臨床薬物動態と骨肉腫の neo-adjuvant 療法. 臨整外 22:581-589, 1987.

• 28) 菊田敦, 広田貴久, 柳沢正信ほか:小児期骨肉腫の治療研究:小児期骨肉腫に対するOS-88プロトコールの治療成績-組織学的効果判定に基づく化学療法の選択-. 日本癌治療学会誌 29:855-862, 1994.

• 29) 平塚和人, 亀下喜久男, 三橋孝之ほか:小児骨肉腫に対する集学的治療-整形外科の立場から-. 小児がん 29:406-411, 1992.

• 30) Hodson M, Jaffe MR, Jaffe N, et al:Pediatric osteosarcoma:therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 8:1988-1997, 1990.

• 31) Winkler K, Beron G, Delling G, et al:Neoadjuvant chemotherapy of osteosarcoma:results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329-337, 1988.
  pubmed

• 32) Winkler K, Bielack S, Delling G, et al:Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 66:1703-1710, 1990.
  pubmed

• 33) Winkler K, Bielack SS, Delling G, et al:Treatment of osteosarcoma:experience of the Cooperative Osteosarcoma Study Group (COSS). Cancer Treatment and Research 62:269-277, 1993.

• 34) Bacci G, Picci P, Ferrari S, et al:Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72:3227-3238, 1993.
  pubmed

• 35) Bramwell VHC, Burgers M, Sneath R, et al:A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults:the first study of the European Osteosarcoma Intergroup. J Clin Oncol 10:1579-1591, 1992.

• 36) Meyers PA, Heller G, Healey JH, et al:0steogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449-453, 1993.
  pubmed

• 37) Kung FH, Pratt CB, Vega RA, et al:Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood:a Peditric Oncology Group phase II study. Cancer 71:1898-1903, 1993.

• 38) Harris MB, Cantor AB, Goorin AM, et al:Treatment of osteosarcoma with ifosfamide:comparison of response in pediatric patients with recurrent disease versus patients previously untreated:a Pediatric Oncology Group study. Med Pediatr Oncol 24:87-92, 1995.

• 39) Ward WG, Mikaelian K, Dorey F, et al:Pulmonary metastasis of stage II B extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 12:1849-1858, 1994.

• 40) Tabone MD, Kalifa C, Robary C, et al:0steosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 12:2614-2620, 1994.

P.265 掲載の参考文献

• 1) Fernbach DJ, et al:Nephroblastoma and other renal tumors. in Fernbach DJ, et al (ed.):Clinical pediatric oncology. St. Louis, 1991.

• 2) 西平浩一ほか:小児がんの集学的治療:腎芽腫について. こども医療センター誌11:236, 1982.

• 3) 西 寿治, 西平浩一ほか:腎芽腫に対する治療の現況-外科治療を中心に-. 小児がん28:705, 1991.

• 4) 西平浩一:Wilms腫瘍. 小児科診療55:2414, 1992.

• 5) 西平浩一:ウイルムス腫瘍, 小児看護12:990, 1989.

• 6) 山本 弘, 西平浩一ほか:Aniridiaを合併した Wilm's tumorに対する外科治療. 小児がん 28:472, 1991.

• 7) D' Angio GJ, et al:The treatment of Wilms' tumor:results of the Second National Wilms' Tumor Study. Cancer 47:2302-2311, 1981.
  pubmed

• 8) D' Angio GJ, et al:Treatment of Wilms' tumor:results of the Third National Wilms' Tumor Study. Cancer 64:349, 1989.
  pubmed

• 9) 横森欣司:ウイルムス腫瘍. 小児内科21:790, 1989.

• 10) Green DM:The treatment of advanced or recurrent malignant genitourinary tumors in children. Cancer 60:602, 1987.

• 11) Farber S, et al:Clinical studies of actinomycin D with special reference to Wilms' tumor in children. Ann NY Acad Sci 89:421, 1960.
  pubmed

• 12) Riccardi VM, et al:Chromosome imbalance in the Aniridia-Wilms Tumor Association:11p interstitial deletion. Pediatr 61:604, 1978.

• 13) Pelletier J, et al:WT1 mutations contribute to abnormal genital system development and hereditary Wilm's:tumor. Nature 353:431, 1991.
  pubmed

• 14) Drash A:JPdiatr 76:585, 1970.
  pubmed

• 15) 日本病理学会小児腫瘍組織分類委員会:小児泌尿器腫瘍 (小児腫瘍組織分類図譜1), 金原出版, 東京, 1988.

• 16) Green M, et al:The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study. Am J Pediatr Hematol Oncol 16:207, 1994.

P.281 掲載の参考文献

• 1) Thurbeck WM, Scully RE:Solid teratoma of the ovary, A clinicopathological analysis of 9 cases. Cancer 13:804-811, 1960.

• 2) Altman RP, et al:Sacrococcygeal teratoma:American Academy of Pediatrics Surgical Section Survey, 1975. J Pediatr Surg 9:389-398, 1974.

• 3) Asamura H, Tsuchiya R, Kondo H, et al:Malignant gerem cell tumor of the mediastinum:A multimodality therapeutic approach. Surgery Today 24:137-141, 1994.

• 4) Richie JP, et al:Modified retroperitoneal lymphadenectomy for clinical stagel testicular cancer. J Urol 144:1160-1163, 1990.

• 5) Jewett MAS, et al:Nerve-sparing techniques in retroperitoneal lymphadenectomy in patients with low stage testicular cancer. Semin Urol 6:233-239, 1988.

• 6) Fossa SD, et al:Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 10:569-573, 1992.
  pubmed

• 7) Steyerberg EW, et al:Prediction of residual retroperitoneal mass histology after chemothrapy for metastatic nonseminomatous germ cell tumor:multivariate analysis of indivudual patient data from six study groups. J Clin Oncol 13:1177-1187, 1995.

• 8) Einhorn LH, Donohue JP, et al:Cis-diaminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977.

• 9) Einhom LH:Chemotherapy of disseminated germ cell tumors. Cancer 60:570-573, 1987.

• 10) Williams SD, et al:Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Eng J Med 316:1435-1440, 1987.

• 11) Einhorn LH, Williams SD, et al:Evaluation of optomal duration of chemotherapy in favorable prognosis disseminated germ cell tumors:A Southeastem Cancer Study Group Protocol. J Clin Oncol 7:387-391, 1989.

• 12) Einhom LH, Williams SD, et al:Phase III study of cisplatin dose intensity in advanced germ cell tumors:ASECSG and SWOG protocol. Proc Am Soc Clin Oncol 9:132, 1990.

• 13) Mead GM:Identification and management of poor progriosis germ cell tumors-a need for consensus. Eur J Cancer 29:2217-2218, 1993.

• 14) Bosl GT, et al:Arandamized trial of etoposide+cisplatin versus vinblastine+bleomycin+cisplatin+cyclophpsphamide+dactinomycin in patients With good-prognosis germ cell tumors J Clin Oncol 6:1231-1238, 1988.

• 15) Levi JA, Raghavan D, et al:The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. J Clin oncol 11:1300-1305, 1993.
  pubmed

• 16) Stoter G, Kayte S, et al:Cisplatin (P) and VP 16 (E)+/-bleomycin (B) (BEP vs EP) in good risk patients with disseminated non-seminomatous testicular cancer; A randamized EORTC GU Group Study. Proc Am Soc Clin Oncol 6:110, 1987.

• 17) Loehrer PJ, et al:Importance of bleomycin in favorable prognosis disseminated germ cell tumors:An Eastem Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995.

• 18) Horwich A, Deamaley DP, Nicholls J, et al:Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol 9:62-69, 1991.

• 19) Bajorin DF, et al:Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors:A multiinstitutional study. J Clin Oncol 11:598-606, 1993.
  pubmed

• 20) Ghosn M, et al:Salvage chemothrapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. Cancer 62:24-27, 1988.

• 21) Harstrick A, et al:Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell tumor. J Clin Oncol 9:1549-1555, 1991.

• 22) Patrick J, et al:Salvage therapy in recurrent germ cell cancer:ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988.
  pubmed

• 23) Lcchrer PJ, Einhorn LH, et al:PhaseIII study cisplatin (P) plus etoposide (VP-16) with either bleomycin (B) or ifosfamide (I) in advanced stage germ cell tumors (GCT):An intergroup trial. Proc Am Soc Clin Oncol 12:261, 1993.

• 24) Droz Jp, Pico JL, et al:Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. Eur J Cancer 27:831-835, 1991.
  pubmed

• 25) Nichols CR, et al:Dose-intensive chemotherapy in refractory germ cell cancer-A phasel/II trial of high dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939, 1989.

• 26) Nichols CR, et al:High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer:An Eastern Cooperative Oncology Group Protocol. J Clin Oncol 10:558-563, 1992.
  pubmed

• 27) Motzer RJ, et al:High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Cancer 69:550-556, 1992.
  pubmed

• 28) Adkins J, et al:Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplantation 12:541-546, 1993.

• 29) Wolff SN, et al:High-doseN, N'N-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation:Phase I studies. Semin Oncol 17:2-6, 1990.

• 30) Devalck C, et al:Long-term disease free survival in a child with refractory metastatic malignant germ cell tumor treated with high-dose chemotherapy with autologous bone marrow rescues. Med Ped Oncol:208-210, 1994.

• 31) Hawkins EP, et al:Nongeminomatous malignant germ cell tumors in children. Cancer 58:2579-2584, 1986.

• 32) Pinkerton CR, Pritchard J, et al:High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. J Clin Oncol 4:194-199, 1986.
  pubmed

• 33) Mann JR, et al:Aresults of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 63:1657-1667, 1989.

• 34) Ablin AR, et al:Results of treatment of malignant germ cell tumors in 93children:A report from the Children's Cancer Study Group. J Clin Oncol 9:1782-1792, 1991.

• 35) Pinkerton CR, et al:"JEB"-A carboplatin based regimens for malignant germ cell tumors in children. Br J Cancer 62:257-262, 1990.
  pubmed

P.299 掲載の参考文献

• 1) 渡辺 至:本邦における小児肝癌の手術成績. 18外科施設の集計. 日小外誌10:71-75, 1974.

• 2) Pontisso P, Morsica G, Ruvoletto MG, et al:Latent Hepatitis B virus infection in childhood hepatocellular carcinoma. Analysis by polymerase chain reaction. Cancer 69:2731-2735, 1992.
  pubmed

• 3) Ishak KG, Glunz PR:Hepatoblastoma and hepatocarcinoma in infancy childhood. Report of 47 cases. Cancer 20:396-422, 1967.
  pubmed

• 4) Kasai H, Watanabe I:Histologic classification of liver cell carcinoma in infancy and childhood and its clinical evaluation. Cancer 25:551-563, 1970.

• 5) 豊坂昭広, 岡本英三:小児肝癌の組織分類-新しい組織分類の提案-小児外科14:413-424, 1982.

• 6) Leuschner I, Schmidt D, Harms D:Undifferentiated sarcoma of the liver in childhood; Morphology, flow cytometry and literature review. Hum Pathol 21:68-76, 1990.
  pubmed

• 7) Nakagawara A, Lkede K, Tsuneyoshi M, et al:Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature. Cancer 56:1636-1642, 1985.

• 8) Haas JE, Muczynski KA, Krailo M, et al:Histopahtology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64:1082-1095, 1989.

• 9) Couinaud C:Le foie, etudes anatomiques et chirugicales. Masson&Cie, Paris, 1957.

• 10) Herman RE, Londale D:Chemotherapy, radiotherapy, and hepatic lobectomy for hepatoblastoma in an infant. Report of a survival. Surgery 68:383-388, 1970.

• 11) Evans AE, Land VJ, Newton WA, et al:Combination chemotherapy (vincristine, adriamycin, cyclophosphamide and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50:821-826, 1982.
  pubmed

• 12) Ortega JA, Krailo MD, Haas JE, et al:Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy:a report from the Childrens Cancer Study Group. J Clin Oncol 9:2167-2176, 1991.
  pubmed

• 13) Feusner JH, Krailo MD, Haas JE, et al:Treatment of pulmonary metastasis of initial stage I hepatoblastoma in childhood. Cancer 71:859-864, 1993.

• 14) Douglass EC, Finegold RM, Cantor AB, et al:Cisplatin, Vincristine, and fluorouracil therapy for hepatoblastoma:A Pediatric Oncology Group Study. J CIin Oncol 11:96-99, 1993.

• 15) Andrassy RJ, Brenann LP, Siegel MM, et al:Preoperative chemotherapy for hepatoblastoma in children:Report of six cases, J Pediat Surg 15:517-522, 1980.

• 16) Weinblatt ME, Siegel SE, Siegel MM, et al:Preoperative chemotherapy for unresectable primary hepatic malignancies in children. Cancer 50:1061-1064, 1982.
  pubmed

• 17) Douglass EC, Green AA, Wrenn E, et al:Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 13:187-190, 1985.
  pubmed

• 18) Quinn JJ, Altman AJ, Robinson TH, et al:Adriamycin and cisplatin for hepatoblastoma. Cancer 56:1926-1929, 1985.
  pubmed

• 19) Pierro A, Langenin AM, Filler RM, et al:Preoperative chemotherapy in unresectable hepatoblastoma. JPediatr Surg 24:24-29, 1989.

• 20) Filler RM, Ehrlich PF, Greenberg ML, et al:Preoperative chemotherapy in hepatoblastoma. Surgery 110:591-597, 1991.
  pubmed

• 21) Ninane J, Perilongo G, Stalens Jp, et al:Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma:A SIOP pilot study. Med Pediatr Oncol 19:199-203, 1991.

• 22) Ikeda K, Suita S, Nakagawara A, et al:Pre-operative chemotherapy for initially unresectable hepatoblastoma in children. Arch Surg II 4:203-207, 1979.

• 23) Tsuchida Y, Bastos JC, Honna T, et al:Treatment of disseminated hepatoblastoma involving bilateral lobes. J ediatr Surg 12:1253-1255, 1990.

• 24) 内野純一, 秦 温信:小児肝癌治療の現況. 小児がん28:699-703, 1991.

• 25) Smithson WA, Telander RL, Carney JA, et al:Mesenchymoma of the liver in childhood:Five-year survival after combined modality treatment. J Pediatr Surg 17:70-72, 1982.
  pubmed

• 26) Horowitz ME, Etcubanas HS, Weber BL, et al:Hepatic undifferentiated sarcoma (embryonal) sarcoma and rhabdomyosarcoma in children. Results of therapy. Cancer 59:396-402, 1987.

• 27) Harris MB, Shen S, Weiner MA, et al:Treatment of primary undifferentiated sarcoma of the liver with surgery and chemotherapy. Cancer 54:2859-2862, 1984.
  pubmed

• 28) Ware R, Friedman HS, Filston HC, et al:Childhood hepatic mesenchmoma:Successful treatment with surgery and multiple-agent chemotherapy. Med Pediatr Oncol 16:62-65, 1988.
  pubmed

• 29) Safer AD, Selinkoff PM:Preoperative irradiation and chemotherapy for initially unresectable hepatoblastoma. J pediatr Surg l 2:1001-1007, 1977.

• 30) Habrand JL, Pritchard J:Role of radiotherapy in hepatoblastoma and hepatocellular carcinoma in children and adolescents:Results of a survey conducted by the SIOP Liver Tumour Study Group. Med Pediatr Oncol 19:208, 1991.

• 31) Habrand JL, Nahme D, Kalifa C, et al:Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiation Oncology Biol Phys 23:525-531, 1992.

• 32) Koneru B, Flye MW, Busuttil RW, et al:Liver transplantation for hepatoblastoma. The American Experience. Ann Surg 213:118-121, 1991.
  pubmed

• 33) Tagge EP, Tagge DU, Reyes J, et al:Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma:impact on survival. J Pediatr Surg 27:292-297, 1992.
  pubmed

• 34) 岡本英三, 豊坂昭文, 岡空達夫ほか:小児肝癌の遠隔成績. 日小外会誌25:959-969, 1989.

P.309 掲載の参考文献

• 1) がんの子供を守る会:小児悪性新生物全国登録, 平成元年度 (1989) 小児がん27:459-480, 1991.

• 2) がんの子供を守る会:平成2年度小児悪性新生物・全国登録委員会報告, 小児がん28:733-755, 1992.

• 3) Usenius T, Karja J, Collan Y:Squamous cell carcinoma of the tongue in children. Cancer 60:236-239, 1987.
  pubmed

• 4) Moore C:Visceral squamous cancer in children. Pediatrics 21:573-581, 1958.
  pubmed

• 5) Elliott MJ, Ashcroft T:Primary adenocarcinoma of the gastroesophageal junction in childhood. Scand J Thorac Cardiovasc Surg 17:65-66, 1983.
  pubmed

• 6) 日本小児外科学会悪性腫瘍委員会:小児の外科的悪性腫瘍, 登録症例の全国集計結果の報告. 日小児外会誌19-28:1983-1992,

• 7) 納谷保子, 馬場美子, 武田義廣ほか:急性リンパ性白血病の化学療法終了後に食道癌を発症した一例 (抄録), 第96回日本小児科学会総会.

• 8) 松井 陽:成人型悪性腫瘍, 新小児医学大系24C, 小児腫瘍学皿, p239-264, 中山書店, 東京, 1980.

• 9) 曽和融生, 冬廣雄一, 向井龍一郎ほか:小児胃癌に関する考察-本邦報告例. 外科診療21:849-856, 1979.

• 10) 後藤誠一, 池田恵一, 中川原章ほか:7歳5ヵ月男児にみられた胃癌症例の経験及び本邦15歳以下小児胃癌の統計的観察. 日小児外会誌18:1159-1169, 1982.

• 11) 白石龍二, 西 寿治, 山田亮二ほか:8歳3ヵ月男児の早期胃癌の1例. 日小児外会誌22:68-73, 1986.

• 12) Lack EE:Leiomyosarcomas in childhood:A clinical and pathologic study of 10 cases. Pediatr Pathol 6:181-197, 1986.
  pubmed

• 13) Angerpointner Th A, Weitz H, Haas RJ, et al:Intestinal leiomyosarcoma in childhood. Case reportand review of the literature. J Pediatr Surg 16:491-495, 1981.

• 14) 前田貢作, 布施徳馬, 竹内 正ほか:小児結腸癌, 症例ならびに本邦報告例の検討. 小児外科15:1061-1065, 1983,

• 15) Goldthom JF, Powars D, Hays DM:Adenocarcinoma of the colon and rectum in the adolescent. Surgery 93:409-414, 1983.

• 16) Rao B, Pratt CB, Fleming ID, et al:Colon carcinoma in children and adolescents. Cancer 55:1322-1326, 1985.
  pubmed

• 17) 増田強三, 鈴木 博:直腸癌の統計的観察. 外科治療8:54-58, 1963.

• 18) 山際裕史, 岡林義弘, 多田弘一ほか:近親結婚家系に生じた若年者大腸癌の1例. 臨外30:759-762, 1975.

• 19) 里見 昭, 石田 清, 畑尾正彦ほか:術後10年を経過した小児結腸癌の1例. 日小児外会誌23:908-913, 1987.

• 20) Shimakage M, Ikegami N:Serological follow-up study on the antibody levels to epstein-barr virus-determind nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiationtherapy. Biken Journal 30:5-51, 1987.

• 21) 吉野邦俊, 吉田淳一, 石田 稔ほか:上咽頭悪性腫瘍患者107例の臨床統計. 耳鼻臨床73:450-472, 1981.

• 22) 沢木修二:上咽頭癌. 耳喉50:95-107, 1978.

• 23) Gasparini M, Lonbardi F, Rottoli L, et al:Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children. J Clin Oncol 6:491-494, 1988.

• 24) 勝野真人, 加藤隆司, 坂本純一ほか:気管支mucoepidermoid carcinomaの1小児例. 小児科25:1683-1689, 1984.

• 25) Jack EE, Harris GBC, Eraklis AJ, et al:Primary bronchial tumors in childhood. A clinicopathologic study of six cases. Cancer 51:492-497, 1983.

• 26) 三村 孝, 伊藤國彦:若年性甲状腺癌. 臨外46:1327-1334, 1991.

• 27) Kodama T, Fujimoto Y, Obata T, et al:Justification of conserative surgical treatment of childhood thyroid cancer:Report of eleven cases and analysis of Japanese literature. Jpn J Cancer Res 77:799-807, 1986.

• 28) 遠藤辰一郎, 渡辺岩雄, 梅津昌光ほか:小児甲状腺癌の臨床-特にその特異性について-. 手術21:221-223, 1967.

• 29) Keyser LFM, van Herle AJ:Differentiated thyroid cancer in children. Head & Neck Surg 8:104-114, 1985.

• 30) Schlumberger M, de Vathaire F, Travagli JP, et al:Differentiated thyroid carcinoma in childhood; Long term folow-up of 72 patients. J Clin Endocrinol Metab 65:1088-1094, 1982.

• 31) Thompson NW:Papillary thyroid carcinoma in children and adults:Long-term follow up of 1039 patients conservatively treated at one institution during three decades. Sergery 104:1157-1166, 1988.

• 32) Clark OH:TSH suppression in the management of thyroid nodules and thyroid cancer. Wold J Surg 5:39-47, 1981.

• 33) 岩田光正, 岡部郁夫, 三宅 洋ほか:小児副腎皮質癌の5自験例と本邦報告例の検討. 日小外会誌22:1260-1267, 1986.

• 34) 五味 明, 岡松孝男, 八塚正四ほか:MRIが診断に有効であった小児副腎皮質癌の1例. 日小外放会誌7:140-141, 1991.

• 35) 足立尚登:内分泌腫瘍. 日本臨牀47:636-639, 1989.

• 36) Dowhing V, Eule J, Huseby RA:Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane theraoy; A case report. Cancer 34:1882-1887, 1974.

• 37) 漆原直人, 河野澄男, 長谷川史郎ほか:小児悪性褐色細胞腫. 日小外会誌28:76-86, 1992.

• 38) Averbuch SD, Steakley CS, Young RC, et al:Malignant pheochromocytoma; Effective treatment with acombination of cyclophosphamide, vincristine, and dacarbazine. Ann Int Med 109:267-273, 1988.

• 39) Barber HRK:Managing ovarian tumors of childhood and adolescence, Ovarian carcinoma, 2nd ed., p 131, Masson Publishing USA, Inc., NY, 1982.

• 40) 太田黒和生:小児期の精巣腫瘍. 泌尿器外科 2:1007-1012, 1988.

• 41) 朝比奈美子, 土屋正巳, 山本正生ほか:学校集団検尿を契機として発見された小児腎細胞癌の1例. 小児科臨床37:155-158, 1984.

• 42) Spector BD, Perry GS, Kersey JH:Genetically determined immunodeficiency diseases and malignancy; Report from the immunodeficiency-cancer resistry. Clin lmmunol lmmunopathol 11:12-19, 1978.

• 43) 早川 浩, 矢田純一, 小林 登:わが国における原発性免疫不全症候群の調査成績. 日児誌 83:1510-1528, 1979.

• 44) Gatti RA, Good RA:Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28:89-98, 1971.

• 45) 渡辺 章, 十川英明, 高谷彦一郎:胃癌を発症した14歳男児のAtaxia-telangiectasia症例. 医学のあゆみ 93:587-588, 1975.

• 46) Swift M, Sholman L, Perry M, et al:Malignant neoplasms in the families of patients with ataxia telangiectasia. Cancer Res 36:209-215, 1976.
  pubmed

• 47) 奈良信雄, 宮本忠昭, 栗栖 明ほか:扁平上皮癌を合併したFanconi貧血の姉弟例. 臨床血液 21:1944-1950, 1980.

• 48) Kaplan MJ, Sabio H, Wanebo H, et al:Squamous cell carcinoma in the immunosuppressed patient:Fanconi's anemia. Laryngoscope 95:771-775, 1985.

• 49) 別所文雄:Fanconi貧血を巡る諸問題. 日小血会誌7:105-116, 1993.

• 50) 上野 滋, 石田治雄, 林 奥ほか:慢性型チロジン症に合併した成人型肝癌の1例. 日小外会誌21:853-859, 1985.

• 51) Kraemer KH, Lee MM, Scotto J:DNA repair protects against cutaneous and internal neoplasia:evidence from xeroderma pigmentosum. Carcinogenesis 5:511-514, 1984.
  pubmed

• 52) 近藤靖児, 袋 秀平, 山口 潤ほか:色素性乾皮症の最近の知見. 皮膚臨床 35:233-240, 1993.

• 53) 山本正生, 藤野純子:DeSanctis-Cacchione syndrome (xeroderma pigmentosum with neurological complications) の1例. 日医大誌 37:259-263, 1970.

• 54) 仲 弥, 原田敬之:Maffucci症候群-1例報告と本邦例の集計. 臨皮 42:201-208, 1988.

• 55) Kaplan EN:The risk of malignancy in large congenital nevi. Plastic & Reconstructive surgery 53:421-428, 1976.

• 56) 石原和之:悪性黒色腫. 小児内科 (臨時増刊号):288-292, 1987.

• 57) Cordts AE, Chabot JR:Jejunal carcinoma in a child. J pediatr Surg 18:180-181, 1983.

V. 小児がん患者の管理と生活向上

P.326 掲載の参考文献

• 1) 熊谷昌明, 恒松由記子, 平林万紀子:小児がんの生存率の改善と長期生存の今後の問題. 化学療法の領域 6:756-760, 1990.

• 2) 恒松由記子, 熊谷昌明, 平林万紀子ほか:両親へのアンケート調査による小児がん長期生存者のQuality of life. 癌と化学療法17:PART-II, 1990.

• 3) Bleyer WA:The impact of childhood cancer on the United States and the world. CA 40:355-367, 1990.
  pubmed

• 4) Schwartz CL, Hobbie WL, Constine LS, et al:Survivors of childhood cancer. Assessment and Management. Mosby-Year Book, Inc, 1994.

• 5) 恒松由記子:小児悪性腫瘍の晩期障害と二次発癌. 小児医学の進歩.'91B. 新小児医学体系, pp279-293, 中山書店, 1991.

• 6) Meister LA, Meadows AT:Late effects of childhood cancer therapy. Current Problems in Pediatr p102-131, 1993.

• 7) Blatt J, Copeland DR, Bleyer WA:ed. by Pizzo, Poplack Late effects childhood cancer and its treat-ment in:Principles and Practice of Pediatric Oncology. pp1091-1114, Lippincott.

• 8) Robison LL:Issues in the consideration of intervention strategies in long-term survivors of childhood cancer. Cancer 71 (10):3406-3410, 1993.

• 9) Green DM:Effects of treatment for childhood cancer vital organ system 71 (10):3299-3305, 1993.

• 10) Evans AE, Norkool P, Evans I, et al:Late effects of treatment for Wilms' tumor. Cancer 67:331-336, 1991.
  pubmed

• 11) 恒松由記子, 田口信行, 佐伯守洋ほか:横紋筋肉腫の晩期障害. 小児外科 26 (1):99-103,

• 12) Emani B, Lyman J, Brown A, et al:Tolerance of normal tissue to therapeutic irradiation. Int J pediat Oncol Biol Phys 21:109-122, 1991.

• 13) 熊谷昌明, 恒松由記子ほか:ホジキン病治療10年後に発症した胸骨s紡錐細胞肉腫の1剖検例. 小児がん 27:278-280, 1990.

• 14) Von Hoff DD, Layard MW, Basa P, et al:Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717, 1979.
  pubmed

• 15) Torti FM, Bristow MR, Howes AE, et al:Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Ann Intern Med 99:745-749, 1983.
  pubmed

• 16) Pratt CB, Ransom JL, Evans WE:Age-related cardiotoxicity in children. Cancer Treat Rep 62:1381-1385, 1978.
  pubmed

• 17) Legha SS, Benjamin RS, Mackay B, et al:Reduction of doxorubicin cardiotoxicity by prolonged continuous intraverous infusion. Ann Intern Med 96:133-139, 1982.

• 18) 熊谷昌明, 高橋弘剛, 佐々木道子ほか:Mitoxantrone投与後に重篤な心不全を生じた小児AMLの2例. 臨床血液30:1503, 1989.

• 19) Lipshultz SE, Colan SD, Gelber RD, et al:Late cardiac effects of doxorubicin therapy for acute lymhoblastic leukemia in childhood. N Eng J Med 324:808-815, 1991.

• 20) Steinherz L, Steinherz P, Tan C, et al:Cardiac toxicity 4-20 years after completing anthracycline therapy. JAMA 266:1672-1677, 1991.
  pubmed

• 21) Pohjola-Sintonen S, Tottemlan K, Salmo M, et al:Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 60:31-37, 1987.

• 22) Steinherz LJ, Graham T, Hurwitz R, et al:Guidelines for cardiac monitoring of children during and after anthracycline therapy:Report of the Cardiology Committee of the Children's Cancer Study Group. Pediatrics 89:942-949, 1992.

• 23) Davis LE, Brown CEL:Peripartum heart failure in a patient treated previously with doxorubicin. Bostet. Gynecol 71:506-507, 1988.

• 24) Pascual RS, Mosher MB, Sikand RS, et al:Effect of bleomycin on pulmonary function in man. Am Rev Respir Dis 108:211-217, 1973.

• 25) Miller RW, Fusner JE, Fink RJ, et al:Pulmonary function abnormalities in long term survivors of childhood cancer. Med Pediatr Oncol 14:202-207, 1986.
  pubmed

• 26) Ellis ER, Marcus RB, Cicale MJ, et al:Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma. J Clin Oncol 10:459-463, 1992.
  pubmed

• 27) O'Driscool BR, Hasleton PS, Taylor PM, et al:Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Eng J Med 323:378-382; Goldberg MA, Antin JH, Guinan EC, et al:Cyclophospharnide cardiotoxicity:an analysis of dosing as a risk factor. Blood 68:1114-1118, 1986.

• 28) Sostman HD, Matthay RA, Putnam CE, et al:Methotrexate induced pnemonitis. Medicine 55:371-388, 1976.

• 29) Parker D, Bate CM, Craft AW, et al:Liver damage in children with acute leukemia and non-Hodgkin's Lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharmaco 14:121-127, 1980.

• 30) Topley JM, Benson J, Squier MV, et al:Hepatotoxicity in the treatmant of caute lymphoblastic leukemia. Med Pediatr Oncol 7:393-399, 1979.

• 31) Green DM, Norkool P, Breslow NE, et al:Severe Hepatic toxocity after treatment With Vincristine and dactinomycin using single-dose or divided-dose schedules:A report from the National Wilms' Tumor Study. J Clin Oncol 8:1525-1530, 1990.
  pubmed

• 32) Robitaille P, Mongeau J-G, Lortie L, et al:Long-term follow-up of patients who underwent unilateral nephrectomy in childhood. Lancet 1:1297-1299, 1990.

• 33) Bhisitkul DM, Morgan ER, Vozar MA, et al:Renal function reserve in long-term surviors of unilateral Wilms tumor. J Pediatr 118:698-702, 1990.

• 34) Arneil GC, Emmanuel IG, Flatman GE, et al:Nephritis in two children after irradiation and chemotherapy for nephroblastoma. Lancet 1:960-963, 1974.
  pubmed

• 35) Koskimies O:Arterial hypertension developing 10 years after radiotherapy for Wilms' tumor. Br Med J 285:996-998, 1982.

• 36) Kantor AF, Li FP, Janov AJJ, et al:Hypertesion in long-term survivors of childhood renal cancers. J Clin Oncol 7:912-915, 1989,

• 37) Salvi S, Green DM, Brecher ML, et al:Renal artery stenosis and hypertension following abdominal irradiation for Hodgkin's disease:successful treatment with nephrectomy. Urology 21:611-615, 1983.
  pubmed

• 38) Dention M, Luft FC, Yum MN, et al:Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 41:1274-1281, 1978.

• 39) Hutchison FN, Perez EA, Gandara DR, et al:Renal salt wasting in patients treated with cisplatin. Ann Intern Med 108:21-25, 1988.
  pubmed

• 40) Skinner R, Pearson ADJ, Price L, et al:Nephrotoxicity after ifosfamide. Arch Dis Child 65:732-738, 1990.

• 41) Howell SB, Carmody J:Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults. Cancer Treat Rep 61:1389-1391, 1977.
  pubmed

• 42) Goren MP, Wright RK, Horowitz ME, et al:Enhancement of methotrexate nephrotoxicity after cisplatin therapy. Cancer 58:2617-2621, 1986.
  pubmed

• 43) Jayalakshmamma B, Pinkel D:Urinary-bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy. Cancer 38:701-707, 1976.
  pubmed

• 44) 加藤文代, 恒松由記子, 雉本忠市, 鳶巣賢一:サイクロフォスファミド内服後の重症晩期障害-小児がん治療後に発症した肺線維症と膀胱がんの各一例. 小児がん712, 1991.

• 45) Byrne J, Mulvihill JJ, Myers MH, et al:Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 317:1315-1321, 1987.
  pubmed

• 46) Lentz RD, Bergstein J, Steffes MW, et al:Post pubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty. J Pediatr 91:385-394, 1977.

• 47) Himelstein-Braw R, Peters H, Faber M.:Influence of irradiation and chemotherapy on the ovaries of children with abdominal tumours. Br J Cancer 36:269-275, 1977.
  pubmed

• 48) Stillman RJ, Schinfeld JS, Schiff I:Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139:62-66, 1981.
  pubmed

• 49) Nicosia SV, Matus, Ridley M, Meadows AT:Gonadal effects of cancer therapy in girls. Cancer 55:2364-2372, 1985.
  pubmed

• 50) Byrne J, Fears TR, Gail MH, et al:Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788-793, 1992.
  pubmed

• 51) Li FP, Gimbrere K, Gelber RD, et al:Outcome of pregnancy in survivors of Wilms' tumor. JAMA 257:216-219, 1987.
  pubmed

• 52) Mulvihill JJ, Myers MH, and Austin DF, et al:Cancer in offspring of long-termsurvivors of childhood and adolescent cancer. Lancet II:813-817, 1987.

• 53) Hawkins MM:Is there evidence of a therapy-related. increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 83:1643-1650, 1991.
  pubmed

• 54) Green MD, Zevon MA, Lowrie G, et al:congenital abnormalities in children of patient who recevied chemotherapy for cancer in childhood and adolescence. N Engl J Med 325:141-146, 1991.

• 55) Smith M, Rubinstein L, Ungerleider RS:Therapy-related acute myeloid leukemia following treatment with epipodphyllotoxins:Estimating the risks. Med Pediatr Oncol 23:86-98, 1994.
  pubmed

• 56) Sugita K, Furukawa T, Tsuchida M, et al:High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's Lymphoma. Am J Pediatr Hematol Oncol 15:99-104, 1993.
  pubmed

• 57) Nichols CR, Breeden ES, Loehrer PJ, et al:Secondary leukemia associated with a conventional dose of etoposide:review of serial germ cell tumor protocols. J Natl Cancer Inst 85 (1):36-40, 1993.
  pubmed

• 58) 恒松由記子, 東山由美, 守山由恵:小児がん患者への告知とインフォームドコンセント, 特集 小児治療における告知とインフォームドコンセントの実際. 小児内科26:567-571, 1994.

• 59) Robison LL:issues in the consideration of intervention strategies in long-term survivors of childhood cancer. Cancer 71:3406-3414, 1993.
  pubmed

P.336 掲載の参考文献

• 1) Smart CR, Yates JW:Quality of life. Cancer 60:620-622, 1987.
  pubmed

• 2) Mccartney CF, Larson DB:Quality of life in patients with gynecologic cancer. Cancer 60:2129-2136, 1987.
  pubmed

• 3) Schipper H, Clinch J, McMurray A, et al:Measuring the quality of life of cancer patients:the Functional Living Index-Cancer:Development and validation. J Clin Oncol 2:472-483, 1984.

• 4) Spitzer WO, Dobson AJ, Hall J, et al:Measuring the quality of Life of cancer patients. A Concise QL-Index for use by physicians. J Chronic Dis 34:585-597, 1981.
  pubmed

• 5) Selby PJ, Chapman JA, Etazadi-Amoli J, et al:The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13-22, 1984.
  pubmed

• 6) Aaronson NK, Bullinger M, Ahmedzai S:Amosilar approach to quality-of-life asessment in cancer clinical trials, recent results. Cancer Res 111:231-249, 1988.

• 7) Fayers PM, Jones DR:Measuring quality of life in cancer clinical trials; A review, Stat. Med 2:429-446, 1983.
  pubmed

• 8) Ganz PA, Haskell CM, Figlin RA:Estimating the quality of life in a clinical trials of patients Withmetastatic lung cancer using the Kamofsky performance status and the Functional Living Index-Cancer. Cancer 61:849-856, 1988.

• 9) Lansky SB, List MA, Lansky LL, et al:The measurement of performance in childhood cancer patients. Cancer 60:1651-1656, 1987.
  pubmed

• 10) 飯塚忠史, 番 浩, 津野 博ほか:我が子の悪性腫瘍告知をうけた母親の反応. 日小血会誌3:129-134, 1989.

• 11) 山本正生:小児がんの晩期障害. 日常診療と血液, (掲載予定)

• 12) 恒松由記子, 熊谷昌明, 平林万紀子:両親へのアンケート調査による小児がん長期生存者のQuality of Life. 癌と化学療法17:878-886, 1990.

• 13) 星 順隆:小児がん患児の医療と生活向上に関する調査研究報告, 小児がん患児の医療と生活の問題点. のぞみ, 第90号 (平成5年3月24日), 第91号 (平成5年5月20日), がんの子供を守る会.

• 14) 櫻井 寛, 加藤充子:日常診療と小児がん, 長期生存患者への生活指導, -進学, 職業の選択, 結婚など-. 小児科診療 53:2909-2914, 1990.

• 15) 小川晶子, 長尾 大:骨髄移植後長期生存者の合併症, QOLとカウンセリソグ. 医学のあゆみ 164:711-714, 1993.

• 16) Moe PJ, Lethinen M, Wegelins R, et al:Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand 68:301-303, 1979.

• 17) Catanzarite VA, Ferguson JE; Acute leukemia and pregnancy:A review of management and outcome, 1972-1982. Obstetrical & Gynecological Survey 39:663-678, 1984.
  pubmed

• 18) Gulati SC, Vega R, Gee T, et al:Growth and development of children born to patients after cancertherapy. Cancer Investigation 4:197-205, 1986.

• 19) Green DM, Hall B, Zevon MA:Pregnancy outcome after treatment for acute lymphoblastic leukemia uring childhood or adolescence. Cancer 64:2335-2339, 1989.
  pubmed

• 20) Nygaard R, Clausen N, Siimea MA, et al:Reproduction following treatment for childhood leukemia:A population-base prospective cohort study of fertility and Offspring. Med & Pediatr Oncol 19:459-466, 1991.

• 21) 河村節子, 吉田豊, 木村禧代二:急性白血病長期生存例の妊娠と出産. Int J Hematology 57:98, 1993. 第55回日本血液学会総会 (抄録)

• 22) Mike V, Meadows AT, D:Ango GJ; Incidence of second malignant neplasms in children:Results of an intemational study. Lancet 2:1326-1331, 1982.

• 23) Meadows AT, Baum E, Fossati-Bellani F, et al:Second malignant neoplasms in children:An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985,

• 24) Farwell J, Flannery J; Cancer in relaties of children with central nervous system neoplasms. New Engl J Med 311:749-753, 1984.

• 25) Rimm IJ, Li FC, Tarbell NJ, et al:Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. Cancer 59:1506-1508, 1987.
  pubmed

• 26) Spitalnik PF, Straus FH; Patterns of human thyroid parenchymal reaction following low-dose childhood irradiation. Cancer 41:1098-1105, 1978.
  pubmed

• 27) Kitchin FD, Ellsworth RM; The pleiotrophic effects of the gene for retionblastoma. J Med Genet 11:244-246, 1974.

• 28) Neglia JP, Meadows AT, Robison LL, et al:Second neoplasms after acute lymphoblastic leukemia in childhood. New Engl J Med 325:1330-1326, 1991.
  pubmed

• 29) Pui C-H, Ribeiro RC, Hacock ML, et al:Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med 325:1682-1687, 1991.
  pubmed

• 30) Rubin E Kharbanda S, Gunji H, et al:Activation of the c-jun protooncogenin human myeloid leukemia cells treated with etoposide. Molecular Phammacology 39:697-701, 1991.

• 31) Eguiguren JM, Riberiro RC, Pui C-H, et al:Secondary non-Hodgkin's lymphoma after treatment for childhood cancer. Leukemia 5:908-911, 1991.

• 32) 大川洋二:抗腫瘍剤VPI6による2次白血病および骨髄異形成症候群. 小児科34:257-264, 1993.

• 33) Meadows AT, Krejmas NL, Belasco JB; The medical cost of cure:Sequelae in survivors of childhood cancer. In Van Ery J, Sullivan MO (eds):Status of the curability of childhood cancer, NY, Raven Press, p263-276, 1980.